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The Mountain Gorillas of Central Africa are one of the most highly endangered 
species in the world, with only 740 individuals surviving.  One of the greatest threats to this 
species is disease.  Health of wildlife is continually garnering more attention in the public 
arena due to recent outbreaks of diseases such as West Nile and High Pathogenic Avian 
Influenza.  However, no system currently exists to facilitate the management and analysis of 
wildlife health data.  The research conducted herein was the development and testing of a 
health information monitoring system for the mountain gorillas entitled Internet-supported 
Management Program to Assist Conservation Technologies or IMPACT™.   The system 
functions around a species database of known or unknown individuals and provides 
individual-based and population-based epidemiological analysis.  The system also uses 
spatial locations of individuals or samples to link multiple species together based on spatial 
proximity for inter-species comparisons.  A syndromic surveillance system or clinical 
decision tree was developed to collect standardized data to better understand the ecology of 
 iii
diseases within the gorilla population.  The system is hierarchical in nature, using trackers 
and guides to conduct daily observations while specially trained veterinarians are used to 
confirm and assess any abnormalities detected.  Assessment of the decision tree indicated 
that trackers and guides did not observe gorilla groups or individuals within groups 
similarly.    Data suggests that, to be consistent, trackers and guides need to conduct 
observations even on the day that veterinarians collect data.  Validity and reliability remain 
to be tested in the observation instrument.  Assessment of pathogen loads and distributions 
within species surrounding the gorillas indicates that humans have the greatest pathogen 
loads with 13 species, followed by cattle and chimpanzees (11), baboon (10), gorillas (9), 
and rodents (3).   Spatial aggregation occurred in Cryptosporidium, Giardia, and Trichuris; 
however, there is reason to question the test results of the former 2 species.  These data 
suggest that researchers need to examine the impact of local human and domestic animal 
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THEORETICAL DEVELOPMENT OF AN OBSERVATIONAL HEALTH 
MONITORING INFORMATION SYSTEM FOR THE  





Traditional wildlife management focuses on health and management of the 
population as a whole.  At extremely low population levels, however, an individual 
within the population comprises a relatively large proportion of the total genome and 
conservation of every individual is important to maintain genetic integrity of the 
population.  Although individuals become a focus in these endangered species, the 
population-level processes must still be observed and managed.  To adequately 
manage a species with a critically low population level, conservationists and resource 
managers must place equal emphasis on the status of the individual and the 
population.  Mountain gorillas are a critically endangered species with only 740 
individuals remaining in 2 extant populations.  Every individual gorilla is of 
tremendous conservation value. Since the inception of Mountain Gorilla Veterinary 
Project (MGVP) in 1986, data have been collected to facilitate prevention and treatment 
of disease and injury in mountain gorillas.   Additionally, data are being collected on 
humans and other nonhuman animals in and around the region occupied by the gorillas.  
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Past research suggests that pathogens are being shared among species sympatric with the 
gorillas.  Although research suggests the potential sharing of pathogens, data from 
different projects cannot, at the current time, be integrated to test these hypotheses.   
Much of the data are maintained by individual researchers rather than the funding 
agency or any coordinating agency.  Consequently, 17 years worth of gorilla health data 
exist, but not in a format that can be used in a cohesive analysis to examine the 
potentially devastating impacts of pathogens in the ecosystem and on the gorilla 
population.  This project developed a web-based computer information system called 
IMPACT that will; 1) integrate existing data into a consistent, spatially explicit, 
compatible format, 2) provide a template to guide future data collection in a consistent 
fashion, and 3) facilitate data coordination and analysis across a diverse array of 
projects.  An integrated, spatially explicit, computerized information system 
incorporating standardized definitions, standardized data fields, regular reporting, 
standardized analysis routines and routine output generation, with access capability from 
many parts of the world aid MGVP and other great ape researchers in long-term 






The five species of great apes, the Orangutans (Pongo pygmaeus) of Borneo and 
Sumatra, and the chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas 
of Africa are facing uncertain futures with their long-term sustainability in question 
(Butynski 2001). The most prominent threat to their survival is habitat destruction and 
fragmentation from logging and agricultural activities. The second most serious threat 
relates to the development of roads associated with logging, allowing access and 
transport to and from remote areas providing an infrastructure for a commercial bush 
meat industry.  Disease is ranked the third highest threat, and has risen in public 
awareness due to the highly publicized outbreaks of Ebola virus in western Africa with 
resulting high mortalities in chimpanzees and gorillas.  In protected areas (i.e., 
conservation areas and national parks) where deforestation and bush meat practices are a 
lesser threat, disease is rated as the premier threat.  
In 1998, the Population Habitat Viability Assessment Workshop held by the 
Captive Breeding Specialist Group in Uganda (CBSG 1997) identified disease 
introduction as the highest risk to the sustainability of the two populations of mountain 
gorillas (Gorilla beringei beringei) in the protected areas of the Virunga Massif and 
Bwindi Impenetrable Forest National Park (Werikhe and Miller 1998).  These parks 
have sharp boundaries between the forest and the human communities, with few existing 
buffer zones.  The human communities around the mountain gorilla parks have a density 
of between 423-538 people/km2 (2002 Rwanda Census, Office National de la 
Population [ONAPO], Revue du Rwanda sur population et development, No 38, June 
2003) and a population growth rate of approximately 3.7%/year (Butynski 2001).  The 
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mountain gorilla populations have the greatest number of habituated individuals of any 
ape species and are subjected to intense research and ecotourism programs.  These 
factors, compounded by agricultural practices at the boundaries of the park, promote 
exposure between gorillas, humans, and domestic animals, thus, increasing the risk of 
disease transmission.  The health care within the human and domestic animal 
populations is less then optimal and poor sanitation is common. Genetic research has 
shown that the same species of enteric organisms (Giardia spp., Microsporidea spp. and 
Cryptosporidea spp.) are circulating amongst humans, cattle, and gorillas (Nizeyi et al. 
1999, 2000, 2002).  The prevalence of antibiotic resistance to Enterococcus sp. and E. 
coli is greater than expected in a naïve wildlife population and has a similar pattern to 
human and cattle antibiotic resistance.  Gorillas share approximately 97-98% genetic 
similarity (Sibley and Ahlquist 1984, Hacia 2001) with humans and are susceptible to 
many of the diseases associated with humans, including the zoonotic diseases of 
livestock.  Opportunistic blood samples have shown that the gorillas are naïve to many 
of the diseases of the region (i.e., measles) that can cause high morbidity and mortality 
and therefore gorillas are a high risk population for a serious epidemic (Hastings et al. 
1991).  This concern of disease transmission exists within all great ape research 
communities. 
In the 1997 Uganda Population and Habitat Viability Assessment Workshop, 
participants concluded that “presently, there is no effective mechanism of orderly, 
standardized collection, management and dissemination of data and materials relevant to 
mountain gorilla health.”  The recommendation was to “establish an interactive, 
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international computerized database” providing epidemiological data as the basis for 
developing policies on mountain gorilla health.  
The Mountain Gorilla Veterinary Project (MGVP), supported by the Morris 
Animal Foundation, was formed in 1986 at the request of Dian Fossey to provide 
emergency medicine and pathology services to the Mountain Gorilla Population of 
Rwanda (Cranfield et al. 2002).  Due to low numbers of gorillas in these populations, 
and genetic studies showing that each animal's genetic input into the population's 
genome is important, mountain gorillas are managed on an individual as well as a 
population basis with respect to veterinary care (Cranfield et al. 2002). 
In a MGVP Strategic Planning Workshop in 2000, participants identified 
MGVP’s vision to be “the premier research and health monitoring resource for 
achieving self-sustaining mountain gorilla populations.”  The mission of MGVP as 
agreed by project participants was to improve the sustainability of the mountain gorillas 
by 1) monitoring the health of gorilla populations, 2) providing health care, 3) 
conducting relevant health studies and 4) disseminating information (Cranfield et al. 
2000).  Additionally, “the goals and strategies to enhance the research program were 
determined, reviewed and then prioritized over three days by the group.  The areas of 
enhancement were: 1) monitor, evaluate, and coordinate the Mountain Gorilla 
Veterinary Project research program, 2) improve the biological database and 
preventative medicine program, 3) expand species focus to include other great apes, the 
health of the local human community, and specific problems of other species which 
impact the mountain gorilla populations, and 4) improve dissemination of research 
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findings and health information from the Mountain Gorilla Veterinary Project’s research 
program, as well as other research relating to mountain gorilla health.” 
The need to better handle biological data for the benefit of wildlife health is not 
unique to MGVP.  In 2004, many of the world’s leading great ape health researchers met 
in Leipzig, Germany to discuss the issue of health management.  From this meeting, the 
Great Ape Health Monitoring Unit (GAHMU) was formed.   The excerpt below is taken 
directly from the GAHMU web site at 
http://www.eva.mpg.de/primat/GAHMU/index.htm and explains the mission of 
GAHMU. 
The Great Ape Health Monitoring Unit (GAHMU) is a network of researchers 
from different disciplines concerned about diseases of great apes. 
  
Even though diseases among wild living great apes under human observation 
have been observed by many field workers, detailed information and 
descriptions of first-hand experiences are rarely published or distributed thinly 
among journals with widely disparate academic audiences. For far too long, the 
focus of great ape behaviour researchers, ecologists and conservationists has 
been separated from the one followed by scientists working in the field of great 
ape medical sciences. Today, due partly to severe health problems in great apes 
populations in the wild (Ebola, measles, polio and unexplained cases of death), 
more scientists are calling for a connection between these fields.  
 
A major limitation to progress is the insufficient knowledge about infectious 
diseases and transmission of pathogens in wild great apes. An interdisciplinary 
approach could help to expand the knowledge base for protecting the health of 
great ape populations, with recent Ebola and other outbreaks among great ape 
populations demonstrating that diseases must also be considered a major threat, 
it should provide information about risks of emerging infectious diseases to 
humans and could also help in the understanding of disease evolution and its 
impact on primate evolution.  
 
GAHMU will aid in this progress by providing drafts for health care plans, 
outbreak protocols, and by promoting the development and use of new, non-
invasive methods of monitoring the health of wild great apes, and in cases of 




We are currently engaged in two concrete projects: 
a) Creating a “Great Ape Task Force”, an emergency group of experienced 
veterinarians to support field sites when great apes are showing sever(e) [SIC] 
symptoms or cases of deaths are observed.  
 
b) Obtaining data on pathogens of different great ape populations. Different 
laboratories will screen non-invasive samples for a set of pathogens. This study 
involves a number of great ape field-sites, and additional data will be obtained 
there to analyze the effect of parameters like climate, inter-species contact or 
environmental disruption on disease transmission.  
 
Health monitoring involves the systematic collection and evaluation of general 
health data which can lead to detection of disease at earlier stages when life saving care 
can more easily and effectively be provided.  Disease surveillance, the complement of 
health monitoring, has been defined as the continuing scrutiny of all aspects of 
occurrence and spread of disease pertinent to effective control (Thrushfield 1995).  Early 
detection and management of disease to minimize negative impacts on the population is 
the goal of disease surveillance.  Types of data that are systematically collected and 
evaluated as part of disease surveillance include: morbidity and mortality reports, reports 
of field investigations of epidemics, individual case reports, vaccination and population 
immunity data, and any other relevant epidemiologic data (Last et. al. 2000).  For the 
mountain gorilla, much of this comes from post-mortem pathology reports, 
parasitology/bacteriology studies, and veterinary field notes.   
Although non-invasive samples can be collected regularly (feces, urine, and 
hair), they provide only a limited amount of information about disease status.  Other 
samples, such as blood, tissue, etc., that could provide more diagnostic information, 
require direct physical contact.  Currently, generally accepted intervention policies 
dictate that physical contact interventions only occur in the case of human-induced 
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injury (e.g. snares, and gunshot wounds) or life-threatening disease, therefore only 
immobilized moribund gorillas or gorilla carcasses provide more diagnostic sample 
material.  Although these samples provide important information to fill in gaps in the 
epidemiologic profile, sampling is opportunistic.  With only opportunistic access to 
blood and tissue samples due to the strict non-intervention policy, understanding of 
newly introduced pathogens and the epidemiological profile of wild gorillas has been 
limited. 
The science of epidemiology is well developed and effective tools exist to assist 
in providing a scientific assessment of the health risks of mountain gorillas.  To date, 
however, these tools have not been applied adequately.  A key tool in effective 
epidemiological investigation to assess mountain gorilla populations is information 
technology; specifically well-designed information or expert systems that can be 
manipulated to answer questions important to disease control and health management 
(Adelman 1992).  Information technology and information management is also vital to 
the practice of modern medicine (Shortliffe et al. 2001).  An integrated computerized 
information system incorporating standardized definitions, standardized data fields, 
regular reporting, standardized analysis routines and routine output generation, with 
access capability from many parts of the world will aid MGVP and other great ape 




This project will test the general hypothesis that data collected as part of 
MGVP’s routine project activities, coupled with select special studies, can be organized 
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and processed to provide information relevant for program management, policy making, 
and conservation for great ape species.  Specific objectives are: 
1) Develop the theoretical framework for a health monitoring system for free-
ranging wildlife species called IMPACT (Internet-supported Management 
Program to Assist Conservation Technologies), 
2) Construct, document, and verify the observation components of the system, 
3) Evaluate the effectiveness of IMPACT to integrate disparate research and 
monitoring data into standardized information that, collectively, can provide 
constantly updated baseline denominator data for epidemiological analysis and 
disease outbreak monitoring,  
4) Evaluate the effectiveness of IMPACT to integrate multiple species 
information into an interspecific disease risk assessment analysis, and  
5) Develop a framework for testing the effectiveness of IMPACT to calculate 
epidemiological thresholds, increase detection rates of outbreaks, and reduce 




Development of any information system requires a logical step-by-step approach 
to ensure consistency, applicability, and functionality (Adelman 1992).  The 
development of the IMPACT health management information system will use an 8 step 





Step #1: Database function 
The first step in development is to understand the ecological and 
epidemiological problems associated with mountain gorilla conservation and identify the 
questions that can be addressed by clinical observations organized in a cogent database.  
What are the objectives we want to achieve with the data?  Specifically; we are 
interested in standardized data collection of gorilla and other species health data for 
long-term intra- and interspecies comparison.  What specific health questions are we 
asking, such as what is the annual, seasonal, gender or age-based prevalence of clinical 
signs in mountain gorillas?  What data are available and what is the spatial distribution 
of the data?  Should the system be able to work on more than one species?  How can we 
make the system be multi-species capable, but still retain the objectives of analyzing 
gorilla health?  The MGVP team has been working for numerous years to formulate the 
questions, as well as, the answers.  Additional questions have been raised by the 1997 
Uganda Population and Habitat Viability Assessment Workshop and the newly formed 
GAHMU.  Undoubtedly, even more questions will be raised as data are collected in a 
consistent format and analyzed. 
 
Step #2: Overall system design and integration 
The next step in development is the understanding of the design and integration 
of the whole information system.  Similar to above, we have to ask questions such as: 
what is the format and scope of the existing data?  How do existing data sets that are 
meant to examine different aspects of gorilla health function together; if at all?  What 
will be the format of the data that will be collected in the future?  How can we integrate 
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the “old” data and the “new” data in the future and still answer the questions from step 
#1 above?  Figure 1.1 illustrates a pictorial diagram of existing data (shown as groupings 
or datasets) from MGVP that are currently collected to monitor for gorilla health.  
Figure 1.1a illustrates how much association exists between the different datasets and/or 
current availability of these data for use. Figure 1.1b illustrates the potential expansion 
of usable information that could be gained from the integration of information.  
During this process, thought needs to be invested into how datasets function 
together in a single system.  Detailed analysis of the system needs to be undertaken at 
this point to identify relationships between data sets.  A relational database management 
system or RDMS, in a simplified form, is a series of tabular information that can link 
together through a single or series of common fields or identifiers.  Figure 1.2 illustrates 
how much of the existing data can function together in a relational system with 
identifiers of an individual of a species being the link among the data.  A well developed 
relational database system is extremely flexible and very powerful in terms of 
integrating and analyzing data from many different sources. The process of developing a 
RDMS requires that data entered into the system be in a standardized format.  This will 
ensure consistency and comparability of data. Once standards of data collection are 
established, the system can continue to grow with the addition of new data components 
or datasets in the future.  Data dictionaries that define the variables required for input are 






Step #3: Compartmentalize the system 
Figure 1.2 illustrates the complexity inherent in a multi-faceted information 
system.  To attempt to build such a system in a single pass would ensure errors and 
problems.  Thus, the system should be divided into components (Figure 1.1).  
Components are more manageable than the whole system, and if the associations among 
components (Figure 1.2) are considered, they are simply modules that can be easily 
combined together at a later date.  This also allows for future expansion of the system in 
an easy manner.  Components addressed in this research include a syndromic 
observation component and a specimen collection and test result component.  Other 
components include, employee health data, necropsy data, tourist health data, and 
monitoring data for domestic and wild animals within and around the gorilla parks. 
Figures 1.1 and 1.2 illustrate how the system can be developed to be species 
centric and function for any species of concern.  For any species, many of the 
components are going to be the same.  Samples will be taken, test results provided, 
observation made, locations recorded, etc.  Thus, a system that uses a species database 
as the central hub can have any of the individual components added or removed as 
needed as long as development follows the integration shown in Figure 1.2.  This 
provides flexibility in application to numerous wildlife species. 
 
Step #4: Component development 
This is the most crucial portion of this system.  If each component is not 
developed regarding linkages with other components, the system will not function 
correctly.  Additionally, this is the largest portion of the system development in terms of 
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time and labor.  Although development and refinement is listed as step 4 in the overall 
process, it also occurs during steps 5-7.  To understand the methods of development, 
focus will be on the specimen collection and test results component as an example.   
Specimens are being collected by great ape researchers in the field on a continual 
basis.  These specimens include, but are not limited to, fecal, blood, parasite, and other 
tissue samples.  Specimens are unique to an individual animal whose identity may or 
may not be known and the sample was collected at a unique and known georeferenced 
location and time. Samples are collected and labeled in the field and stored for analysis.  
Most studies, in general, adhere to the following protocol with samples.  Sample 
information is usually entered into some electronic format for storage.  Specimens are 
sent to a laboratory where test results are generated and associated with the specimen.  
These test result data are then entered into electronic format, usually the same 
information file where the original sample information was entered.   
Often, however, samples are collected for the purpose of analysis sometime in 
the future.  These samples, as well as the others, need to be clearly marked with enough 
identifying information to uniquely identify them among all other potential samples.  
The specimen data can be entered into electronic format where a unique identifier can be 
developed.  The issue in this case, is the uniqueness of the identifier for the specimen.  
Test results can be added to the original specimen data at any later date simply by using 
the unique identifier as the linking variable. 
For this process to function, several steps need to occur.  First, the database 
structure for each aspect of the component should be developed.  A database must be 
developed to maintain information on the specimen collected, then a database must be 
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developed to maintain information on the results from test run on the specimen, and both 
databases must be able to be linked back to an individual (known or not) and a spatial 
location.  Specimens collected in the field need to be marked, minimally with the 
following information: date of collection, initials of collector, specimen type, specimen 
species, individual from which it was collected (if known), and location where the 
sample was taken.  The information regarding the specimen is entered into the system 
where a unique identifier is developed either from the information on the specimen, or 
through an automatic numbering system.  This unique identifier is recorded on the 
specimen for future identification. 
Several factors need to be considered when the database is constructed to 
accommodate these data.  Fields in the database need to be standardized for the system 
to work properly.  These standards include such simple issues as how the date should be 
recorded and entered and complex issues such as how do several subsamples or aliquots 
of the same item (i.e. multiple samples from the same feces) get recorded and 
differentiated. Standard data entry forms need to be developed to ensure consistency in 
collection and promote ease of entry of data into the system.  With this step, issues of 
data analysis need to be considered.  Do the data need to be numeric with look-up tables 
for identifiers, or can categorical text information be used?  What are the possible 
values, range, format, etc. that will be allowed for entry?  This aspect needs to be 
examined closely so as to ensure flexibility or rigidity of use.  Establishing domains 
within fields forces researchers to label data in a standard manner. This helps to ensure 
cleanliness of data and limits the amount of data cleaning required at a later date.   
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The final step in this phase is the development and testing of data queries and 
algorithms.  Data are of no value if they cannot be accessed efficiently.  The system 
should be programmed to have pre-defined queries of the data that are commonly run, 
and allow for new queries to be developed.   
 
Step #5: Incorporation of existing data 
Considerable amounts of data have been collected by MGVP field personnel in 
the past (Figure 1.1), however, much of these data are not in a usable form.  Those data 
that are available and accessible (some original datasets have been lost over time) will 
be compiled and incorporated into the new components in Step #4 above.  This stage 
will be variable in the amount of work needed to get different data sets into the system.  
Data existing in electronic format can either be directly imported, or copied into the 
system after reformatting of the data into a standard defined by the IMPACT system.  
Data from previous MGVP research will be the primary source to initially populate the 
databases.  Researchers from these previous studies will be contacted and the data 
requested through MGVP. 
This process will allow for evaluation of the database structure, entry forms, and 
domains of Step #4.  Evaluation of the process from Step #4 above will be conducted 







Step #6: Creation of standardized data entry forms and data dictionaries 
For multiple researchers to collect data that can be entered easily into a health 
monitoring system, standardized data entry forms are required.  Data collection forms 
for each component of the system will be developed to provide the minimal information 
required for monitoring.  These forms should be available for use in several formats.  
Basic paper forms should be available and electronic forms also should be available for 
use on personal data assistants (PDAs). 
PDA systems such as Palm OS® and PocketPC® systems are commonly being 
used for data collection.  Advantages of these systems include ease of use, ability to use 
forms from step #4 above, reduction of data entry errors, automation of data collection, 
speed of data transfer, and reduction in the need to maintain paper and paper trails.  
Therefore, all data entry screens such as the specimen collection form will be ported to a 
system that can be incorporated into PDAs.  The PDAs can then be used in the field, and 
data on specimens collected entered at the time of sampling.  Disadvantages of these 
systems are that they are electronic, requiring battery power and being susceptible to the 
elements.  Integrated GPS units on the systems will prevent errors in collecting 
locational information. This helps prevent errors of date, time, etc. and can ensure the 
generation of a unique sample number for each specimen taken.  Once the researchers 
return from the field, the data can be uploaded directly into the system.  This will negate 
the need for manual data entry at a later date and prevent data entry errors by third party 
individuals not familiar with the data.  
During this process, algorithms will be developed and tested to allow data 
cleaning and screening at the time of data collection and uploading.  This will ensure 
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integrity of the data in the system.  Algorithms will be developed to ensure that multiple 
PDAs collecting data on the same day will maintain unique information.   
Data dictionaries will be developed for each component and database of the 
system.  Dictionaries will define in detail the fields in each database, the structure of the 
data, proper data collection methods, and limitations of the data.   
 
Step #7: Web-based access 
MGVP team members and gorilla researchers are stationed all across the globe.  
This system would not be useful if it were contained in a single location with access 
limited to that location.  Therefore, the system will be developed to have access via the 
World Wide Web.  All forms for data entry will be accessible via the internet through a 
secured, password-protected site.  This will allow international access and ensure 
protection of the data.  With this system, researchers in Africa can upload data from their 
PDAs while laboratory tests can be entered from Maryland, Mississippi, California, etc.  
Additionally, this also will allow researchers across the globe to be able to access and 
query the data at anytime.  During this stage, the system will be devised to allow 
multiple users simultaneous access.  Conflict detection rules for multiple users as well as 
data input rules will be developed to ensure data cleanliness.   
 
Step #8: System integration 
The final phase of development for IMPACT is to combine the individual 
components developed in steps 4-7 above into a single integrated system.   The 
components should be able to be integrated seamlessly because they would be 
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constructed containing the relationships developed in Step #2.  This stage will require 
replication of testing conducted in Step #4.  The relationships of components will be 
tested for efficiency and stability.  Relationships will be indexed for speed of data query 
and search.  
This phase of the development will allow evaluation of objectives 2 and 3 above 
related to integrating disparate datasets together for the purposes of health monitoring 
and disease risk assessment.  Specifically, data from a retrospective study of mountain 
gorilla health being conducted by Lincoln Park Zoo can be integrated with the daily 
monitoring of trackers and guides.  Previous information regarding occurrence of 
disease in mountain gorillas was based almost entirely on anecdotal data.  The 
retrospective study will give baseline information on the epidemiological profile of the 
animals.  There are problems with the retrospective data, however, in that the observers 
only recorded abnormalities and not normalities.  Thus, the combination of the 
retrospective data with the daily observation data will allow a first assessment of 
baseline data on epidemiological “normals” for this population.  As more observation 
data are entered these values should change.  Specifically, the prevalence of 
abnormalities within the population should drop significantly with the addition of the 
observational data due to the biased nature of the retrospective data. 
The system allows for the comparison of multiple species assemblages within 
the same geographic location.  To test this, several data sets from a 2002 study funded 
by the U.S. Air Force that include human, gorilla, chimpanzee, baboon, cattle, and 
rodents will be entered into the system.  The overall pathogen load and prevalence of 
specific shared pathogens will be evaluated based on the species occurring in spatial 
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proximity to one another.  This analysis will test the ability of IMPACT to work across 
multiple species and examine test results from multiple fields in the data set.  Nizeyi et 
al. (1999, 2000, 2002) has shown that the same species of enteric organisms (Giardia 
spp., Microsporidia spp. and Cryptosporidia spp.) are circulating among humans, cattle, 
and gorillas in the Virunga Massif region.   
The principal outcome of this research is a web-based system to monitor and 
maintain information regarding health of free-ranging wildlife.  The system will be the 
backbone of a long-term health monitoring system for the mountain gorilla.  Once the 
system is fully functional, it will provide a framework to test the effectiveness of the 
system to improve mountain gorilla health.  Specifically, the system should reduce the 
time necessary to detect of disease outbreaks, and allow for faster reaction time, thereby 
reducing morbidity and mortality rates due to any specific disease.  As data are entered 
into the system, the thresholds at which a disease incident becomes an outbreak will be 
defined.  Additionally, while the system grows in data, it should refine these thresholds.  
We will be able to define the number of cases that indicate outbreak on an annual, 
seasonal, age-class, and gender basis.  The thresholds will continue to be refined as 
researchers use the system for outbreak detection and intervention.   
The geospatial component of the system will allow ecologically-based questions 
to be asked and potentially answered that could never before be addressed.  Comparison 
of infections by multiple pathogens to other vertebrate species within a spatial context 
has not been conducted in any study to date.  This new approach to assessing disease 
concentration and spread could provide tremendous insight into the long-term 
management of the isolated endangered species like the mountain gorilla. 
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Because several organizations around the world have expressed great interest in 
the system, it has the potential to become the building blocks for the Great Ape Health 
Monitoring Unit.  A single system that ensures the standardization and quality of data on 
a long-term basis to aid in epidemiological and ecological assessments of health and 
change in the ecosystem is a revolutionary concept to wildlife management.  The fact 
that numerous institutions working with different wildlife species are willing to put data 
into a consistent format for data comparison is virtually unheard of, especially in the 
great ape research community.   
This dissertation outlines the development and testing of a health information 
monitoring system for the mountain gorilla.  This chapter introduced the conceptual 
design of the system.  Chapter 2 discusses the issues faced while constructing a system 
designed to work in developed and developing countries.  Chapter 3 outlines a 
theoretical decision framework for use of observational data to detect, control, and 
prevent disease outbreaks within the gorilla population. Chapter 4 provides an 
assessment of the effectiveness of the decision framework of chapter 3 in terms of 
implementation.  Chapter 5 examines the spatial distribution of samples collected in past 
studies and the pathogens detected within the samples.  Chapter 6 provides a summary 
of all the work completed in this project and lists the potential this work has on gorilla 
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Figure 1.1. Existing Mountain gorilla research projects and data with existing linkages (A) 
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PHYSICAL DEVELOPMENT OF AN OBSERVATIONAL HEALTH 
MONITORING INFORMATION SYSTEM FOR THE MOUNTAIN GORILLA  
 
ABSTRACT 
The health of wildlife populations has received more and more attention over the 
last 20 years.  The expansion of human populations and the corresponding fragmentation 
of the landscape have significantly altered the ecology and distribution of wildlife 
diseases.  Although researchers have been monitoring aspects of wildlife health for 
years, no system has been developed to standardize the information captured or how the 
data are integrated together.  The Mountain Gorilla Veterinary Project has been 
collecting health information on the endangered mountain gorilla (Gorilla beringei), 
humans, livestock, and other wildlife species in Bwindi Impenetrable Forest National 
Park and the Virunga Massif of central Africa for 19 years.  A web-based syndromic 
health monitoring system called IMPACT™ has been developed to collect and analyze 
these data.  The system is designed to facilitate individual and population level health 
assessments.  The system accepts known individuals (e.g., habituated gorillas and 
humans) and unknown individuals (e.g., cattle and wild gorillas) to produce population 
and individual level statistics.  A spatial location allows users to conduct proximity 
analysis across species to characterize elements of ecosystem health.  Although the 
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system was developed around the mountain gorilla, it has application for species in any 





Alteration and fragmentation of landscapes on a global scale, coupled with 
human population expansion has had significant effects on the ecology of wildlife and 
wildlife diseases (Munson and Karesh 2002).  The reduction in amount of available 
habitat in ecosystems has caused greater interaction between wildlife and domestic 
animals (Munson and Karesh 2002).  Human expansion, along with the 
accommodating livestock, also has increased the contact among these species.  These 
new interactions have allowed for the translocation of pathogens to new locations and 
hosts (Wilson 2000). 
Interest in the aspects of wildlife health and disease monitoring has increased 
dramatically over the last 2 decades (Meffe 1999).  Reasons for this burgeoning 
interest in wildlife health include the effect that infectious and non-infectious diseases 
have on wildlife, recent outbreak of diseases within the livestock and human 
communities, and the general lack of information on diseases as it relates to recovery 
of endangered species (Cooper 1998).  Robust estimates of rates of infection, natural 
levels of endemism of diseases and other baseline information on animal health does 
not exist for most wild animals.  Recent outbreaks of zoonotic diseases such as Ebola 
(Morell 1995), monkey pox and Marburg, as well as, the recent issue of global 
terrorism with biological weapons have increased the overall interest in this arena.  
Although interest in wildlife disease issues would appear to be a relatively 
new development, Leopold (1933) noted that “the role of disease in wildlife 
conservation has probably been radically underestimated”.  Similarly, a wildlife 
health monitoring program was established in Sweden in 1945 due to the concern of 
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landowners regarding death of wildlife species on their lands (Morner 2002).  
Monitoring of toxicological impacts on wildlife is a well established discipline 
(Carson 1962, Borg 1966). However, monitoring of diseases of wildlife has focused 
on those pathogens that impact domestic livestock (Pastoret et al. 1988, Plowright 
1988), were zoonotic (Friend 1976), or impacted economically important wildlife 
species (Pearson and Cassidy 1997). 
Great apes, the orangutans (Pongo pygmaeus) of Borneo and Sumatra, and the 
chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas (Gorilla sp.) of 
Africa are facing uncertain futures with their long-term sustainability in question 
(Butynski 2001).  The most prominent threat to their survival is habitat 
destruction/fragmentation from logging and agricultural activities.  The second most 
serious threat relates to the development of roads associated with logging, allowing 
access and transport to and from remote areas providing an infrastructure for a 
commercial bush meat industry.  Disease is usually considered the third most serious 
threat, and has risen in public awareness due to the highly publicized outbreaks of 
Ebola virus in western Africa with resulting high mortalities in chimpanzees and 
gorillas (Morell 1995).  In protected areas (i.e., conservation areas and national parks) 
where deforestation and bush meat practices are a lesser threat, disease is rated as the 
premier threat. 
In regions where endangered species are highly valued socially, extra efforts 
are often needed to conserve the species.  When species population levels are low 
enough that concern for the genetic integrity of the overall population is valid, each 
individual within the population is important.  In this scenario, we must augment the 
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typical conservation approach of dealing primarily with populations with an 
individual-based approach.  Each individual contains a significant amount of the 
genetic diversity for the entire species, thus, emphasis needs to be placed on the 
health and welfare of individuals. 
In regions, such as Bwindi Impenetrable Forest National Park and the Virunga 
Massif of Central Africa, highly-valued, endangered species, such as the mountain 
gorilla (Gorilla beringei), have been historically managed as separate from the 
ecosystem.  At issue is management of these species at the individual level, while 
managing the remainder of the ecosystem at population levels.  Today, conserving the 
health of terrestrial animal populations is now integrated into the overall management 
of ecosystem health (Munson and Karesh 2002).   
Currently, the Mountain Gorilla Veterinary Program (MGVP) and 
governmental conservation office veterinarians monitor the health of the gorilla 
populations by observation, non-invasive biological sampling, and post-mortem 
examination.  Access to invasive biological samples, such as blood, tissue, etc., is 
limited to collection during interventions for life threatening problems and available 
archived material.  Therefore, a syndromic surveillance system is needed to monitor 
and evaluate mountain gorilla health on a daily basis.  Rwego (2004) determined that 
field observation of clinical signs of mountain gorillas was possible.  In the 1997 
Uganda Population and Habitat Viability Assessment Workshop, participants 
concluded that “presently, there is no effective mechanism of orderly, standardized 
collection, management and dissemination of data and materials relevant to mountain 
gorilla health.”  The recommendation was to “establish an interactive, international 
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computerized database” providing epidemiological data as the basis for developing 
policies on mountain gorilla health. 
The observation health monitoring system described herein is part of a larger 
overall health monitoring program developed by the Mountain Gorilla Veterinary 
Project called IMPACT.  IMPACT is an acronym for Internet-supported Management 
Program to Assist Conservation Technologies. This paper describes the theoretical 
development of this syndromic surveillance system and initial implementation. 
 
METHODS 
The initial hurdle for the development of a syndromic health monitoring 
system is to determine what aspect of health should be monitored.  Seven parameters 
and 26 clinical signs were chosen for observation of gorilla health (Table 2.1).  The 
system was designed in a hierarchical fashion, such that an observer would first 
examine one of the body parameters in its entirety, and if abnormal, describe the 
abnormality using the clinical signs.  The seven parameters chosen for initial 
examination were; body condition, activity, respiration, integumentary, discharge 
from the head, discharge from other parts of the body, stool, and other (includes 
central nervous system, etc.).  Within each parameter, specific signs were developed 
to refine possible diagnoses.  Rwego (2004) tested the data collection system to 
ensure that all parameters and signs were able to be observed and recorded in the 
field. 
These clinical parameters were chosen because they are part of other 
observation systems that have proven effective and they are symptomatic of what are 
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thought to be the diseases of major concern for gorillas (Nutter, et al. 2005).  Other 
observation systems that have been used on great apes include cyber tracker and 
Gombe observation. These systems have had varying degrees of success in 
implementation.  One aspect of similarity amongst these systems is the parameters 
that were observed.  Because veterinarians can not physically handle the animals nor 
ask them about symptoms, they are restricted to viewing the animals for signs of 
disease or other problems. 
Respiratory diseases have long been thought to be a major source of fatalities 
in mountain gorillas (Nutter, et al. 2005).  Respiratory diseases, such as pneumonia, 
have many symptoms that can be indicative at onset.  The parameters and signs for 
observation, such as respiration (coughing) and discharge from the head, were 
selected with this in mind. 
Within each of these parameters, clinical signs were established to refine the 
abnormality (Table 2.1). For example, under the parameter of body condition, we 
have the sign of abdomen.  Finally, within each sign, a level of severity of 
abnormality was defined.  Within the sign of abdomen, we have the possible choices 
of normal, flat and sunken.  The choices of flat and sunken indicate 2 levels of 
severity for this sign.  A flat abdomen is less severe a sign than a sunken abdomen.  
Gorillas tend to have a more rotund abdomen under healthy conditions.  Table 2.1 
provides a listing of all the clinical signs chosen for observation with definitions 
(Rwego 2004, MGVP Decision Tree Writing Group In Press).  
Although some of the clinical signs are somewhat subjective, the definition 
for the levels of severity within each sign helps remove some subjectivity (Table 2.1).  
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Additionally, training of field personnel to distinguish normal from abnormal and 
levels of severity within abnormality is required.  Training materials containing 
photographic and/or video footage of live individuals proved useful in training 
observers to differentiate normality from abnormality (Figure 2.1).  These pictorial 
representations of the signs at different levels of severity provide additional 
reinforcement to the trainees.  
This syndromic surveillance system for the mountain gorillas was designed to 
function at the population and individual level.  The importance of the individual in 
the genetic pool required the system to be able to track any individual over time to 
examine changes in health, and generate population level summaries.  Consequently, 
individuals in the population need to be uniquely identifiable.   Nearly 2/3 of the 
estimated 740 mountain gorillas are known and named via unique nose prints.  Most 
of these gorillas are visually located on a daily basis.  This allows the system to be 
based around a population of known individuals.  If the system needed to only be 
used at the population level, it could easily work for any population where individuals 
are not known; calculating the occurrence of clinical signs at the group or population 
level from all individuals documented. 
A demographic table was developed to maintain information such as gender, 
date-of-birth, parental lineage, and date-of-death for all the gorillas.  This information 
strengthened the capability of the system by allowing researchers to examine the 
effects of gender, age, and lineage on risk of clinical sign or death. 
The IMPACT system was designed using a relational database system to 
maintain health information.  The freeware database of MySQL was used for data 
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storage and the php programming language was used for the development of the 
interface to the database. Data are maintained in a manner to provide an assessment 
or case history of a single individual within the population or the group or population 
as a whole.  Researchers may need to evaluate the progression of a disease through 
the clinical signs that develop over time.  This individual assessment provides insight 
into how others within the group may respond to the same illness.  
Additionally, the group or population needs to be monitored at the same time 
to evaluate the rate of spread of the disease within the population.  Basic 
epidemiological curves or incident rates are often used for this purpose (Thrushfield 
1995).  If the population is in a potential outbreak situation, plans need to be 
developed if treatment is deemed necessary and is a viable option (Chapter 3).  Thus, 
the system accumulates data on groups and populations to provide baseline 
information as to what is expected in terms of clinical signs.  Similarly, it may be 
important to evaluate the spread of disease among species.  Spatial location 
information allows the analysis of disease spread across groups, sub-populations, or 
species. Thus, global positioning system (GPS) locations are taken at all sampling 
locations.   
The gorillas occur in multiple locations within their range and are observed by 
more than one individual, therefore, provisions need to be developed for a multi-user 
system.  With this, all observers need to be able to maintain a current database of 
individual gorillas (with births and deaths) and observation records of other 
observers.  Currently there are gorilla groups that will migrate across country borders 
 
 34
in the Virunga Massif, thus, observers in each of the countries need to maintain 
current information on the group in case they show up at their location. 
Because all epidemiological profiles require knowledge of the total number of 
individuals within the group or population, it is imperative that each observer know 
how many individuals exist.  If an animal dies and this information is not updated in 
the database used by other observers, the estimate of overall rate of infection (or 
observability of a sign) will be biased low.  In very small populations, this situation 
can have significant impact on estimates of epidemiological parameters. 
An additional problem that can affect the epidemiological profile of the 
mountain gorillas when examined at a group level is migration of individuals between 
groups.  To get quality estimates of rates of signs, all individuals seen on a given 
observation need to be recorded.  Thus, the system is able to either add unknown wild 
animals to an observation, or add known individuals from another group to an 
observation.   
 
RESULTS 
The development of the IMPACT program has proven most challenging.  An 
electronic version of the data collection form was developed for handheld personal 
data assistants (PDA) (Figure 2.2).   The PDA program provided the observer with a 
complete list of known gorillas and gorilla groups in the Virunga Massif and Bwindi 
Impenetrable Forest National Park (Figure 2.3).  Data entry for most items was a 




The main component of the IMPACT system was a web-based data 
management system (Figure 2.5).  The system was password secured to prevent 
unauthorized access to data on these endangered animals.  All components 
programmed into the PDA also were available on the web-based system (Figure 2.6).  
This allowed for entry of information if observers used a paper form for data 
collection.  Entry from the PDA data collection program was through an import 
function.  Upon import, the data are analyzed and summarized (See Table 3.2, 
Chapter 3).  The IMPACT program also produces summaries of information in a 
visual format to aid protected area managers with management decisions (Figure 2.7).  
As of July 1, 2006, there are over 1000 observation records in the IMPACT system.  
The number of observations will expand exponentially as the system evolves from the 
testing phase to the implementation phase. 
Researchers in different areas of the Virunga Massif tend to collect GPS data 
in different coordinate systems.  Some researchers collect data in the Universal 
Transverse Mercator, whereas others collect data in Latitude and Longitude.  This 
presents issues upon data entry and analysis.  These data must be converted to be 
spatially comparable.  The system was designed such that individuals inputting data 
are required to select either UTM or LAT/LONG as a coordinate system.  This allows 
the system to automatically convert the coordinates to a standard system.  Latitude 
and longitude with the underlying datum of the World Geodetic System of 1984 
(WGS84) is the standard for data storage. 
Spatial referencing information provides greater flexibility of the data.  Spatial 
location information on daily observations can be used to calculate home ranges 
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(Figure 2.8) or simply examine the spatial distribution of a specific disease (Figure 
2.9). 
One aspect of the development of the IMPACT system that was initially 
overlooked was the size and complexity of the web pages.  The IMPACT system 
could have been developed much more easily using the internet capabilities of 
developed countries.  Creating the system to function at the level of a field station in 
central Africa was much more challenging.  All web pages were developed to be less 
than 100 KB in size and most were less than 50 KB in size.  Additionally, most pages 
could not be dynamic in nature.  A dynamic page requires reloading at every change; 
this was not feasible at a transfer rate of 500-900 bytes/sec. as experienced in Africa. 
Any system based on observation of wild animals requires testing.  Testing 
needs to be conducted to ensure that the parameters and clinical signs can actually be 
observed.  Rwego (2004) demonstrated that the parameters and signs established in 
the observation system could be observed.  Additionally, he documented that 
observability of signs differed across gender and age classes (Figure 2.10).  The 
reliability and validity of any survey instrument also needs to be tested.  If an 
instrument cannot produce consistent results across multiple observers, or if the 
results are not indicative of actual events, then it is not a useful tool.  The observation 
system is currently being evaluated under controlled experimentation for validity and 
reliability.   
DISCUSSION 
The ecology of wildlife diseases has changed rapidly over the last decades.  
Alteration and fragmentation of the landscape due to human expansion and resultant 
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shifts in wildlife populations has increased interspecies contact; translocating 
pathogens to new locations and hosts (Wilson 2000).   
Munson and Karesh (2002) provided suggestions for integrating animal health 
into conservation management strategies.  They suggested that a new realm of 
conservation is developing.  This realm of conservation is multi-disciplinary in that it 
links wildlife ecology with veterinary medicine.  Many people are calling the field 
“conservation medicine.”  Munson and Karesh (2002) suggested that given the right 
sentinel species, a means of monitoring the ecosystem would be feasible.  Thus, a 
health monitoring system that is capable of dealing with any species with either 
known or unknown individuals can be applied on a worldwide scale.  The IMPACT 
system is designed with this aspect in mind.  Although it has been developed around 
the mountain gorillas of central Africa, it can be applied to any species in any location 
around the globe. 
Because of the intervention policies in place around the mountain gorillas, it is 
not possible to physically handle or treat animals for routine monitoring.  Therefore, 
MGVP is restricted to the use of this syndromic surveillance system.  As more and 
more data are collected on the presence of clinical signs, we can start to compare the 
progression of signs in an individual as it relates to specific diseases and how these 
signs spread throughout the group as the disease spreads.  Currently, signs or 
combinations of signs have not been tested to be quality predictors of specific 
diseases.  This testing process will need to be conducted as more and more reliable 
data on the gorillas is amassed.  Signs may be gender and age class specific with 
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some diseases.  The system described herein will be able to handle this issue using the 
demographic information associated with each observation. 
As information on the prevalence of clinical signs comes available, Protected 
Area Managers and MGVP veterinarians will have greater recourse to suggest 
treatment of individuals to prevent spread of disease and possible death.  A clinical 
decision tree to determine when the number and type of signs is considered an 
outbreak has already been defined (Chapter 3, MGVP Decision Tree Writing Group 
In Press).   As more information amasses in the IMPACT system, a change in the 
intervention policies of Uganda, Rwanda and Democratic Republic of Congo will 
likely occur.   Countries will likely be more open to intervention if it can be shown 
that individuals have a high probability of mortality with a specific combination of 
clinical signs or if spread of disease is likely. 
The IMPACT system is still evolving and developing. As it does, other 
research groups will see the benefit of monitoring wildlife populations for health.  
The Lincoln Park Zoo, in conjunction with the Jane Goodall Institute, has already 
adopted the use of the program for chimpanzees in their main study area in Gombe, 
Tanzania.  Additionally, the Wildlife Conservation Society (WCS) field veterinary 
program is teaming up with MGVP to expand the program to include GIS analysis of 
observation and test results of biological samples. WCS has plans to use the program 
worldwide for threatened and non-threatened species alike.  Both organizations see 
the benefit of using a system like IMPACT to maintain health related information and 
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Table 2.1. The data dictionary of the clinical parameters and signs with severity 
ratings for the clinical decision tree of the Mountain Gorilla Veterinary Project. 
 
  Severity Rating 






Body Condition: the 







terms of muscle 
mass and body fat 
Unable to see the 
ribs and muscles 
appear normal 
Thin: a) estimated 
<10% loss of weight 
b) able to see the 
ribs 
c) notable muscle 
atrophy 
Very thin: a) >10% 
loss of body weight 
b) ribs obviously 
pronounced 




 Abdomen: part of 
the body that lies 
between the thorax 
and the pelvis 
Abdomen extends 








sunken and concave 
Activity: Quality of 
being active 
General Attitude: 
The manner of 
acting 
Age and sex 
specific appropriate 
behaviors 
Behavior not like 
rest of the members 
at a particular time 
of day or in a 
particular context. 




behaviors in the 
context of the 
environment. e.g. 
still in the nest after 
9 am or at one spot 
> 1 hour with no 
body manipulation 
 
 Manipulation: Any 
manual movement 




of the limbs of the 
body 
Unable to perform 
normal movements 
of any part(s) of one 
or more limbs 
Unable to perform 
normal movements 
of any part(s) of 
one or more limbs, 
high degree of 
dysfunction present 
 
 Movement: The act 
of passing the whole 
body from place to 
place 
Normal movement 
of the whole body 
Lameness: 
Abnormal 
movement of one or 
more limbs leading 
to the individual 
limping 
Severe Lameness: 
unable to keep up 
with the group, 
abnormal 




to respiration which 







as no. of 
breathes/minute 
When the observer 
visualizes the 
nostrils and the 
chest and the animal 
appears comfortable 
and you barely 
visualize  the 
movement of the 
chest and there are 






Slow: Breathing  
observed as <15 
breathes/minute and 
audible sounds 
may/may not be 
heard 
Fast: When 
breathing is >25 
/minute with/ 
without audible 




Table 2.1. (cont.) 
 Breathing difficulty: 



















 Coughing quality: 
Coughing is sudden 
explosive forcing of 
air through the 
glottis & larynx 
 
No coughing Dry: Harsh, grating, 






 Coughing pattern: 
The sequence of 
coughing 
Doesn't interrupt the 




interruption of the 
individuals 
activities due to 
coughing 
Continuous: 
Coughing >1 time 




 Sneezing: Expelling 
air from the nose 












of sneezing that are 
isolated events with 




episode of sneezing 




and all of their 




Skin and Hair: The 
tough membranous 
tissue that forms the 
external covering of 
the individual and 




Skin and hair as 




pieces of epidermis 
sloughing off the 
body  
Loss of hair: 





ulcers , erosions 
pustules, nodules 
maculae, scars, and 
thickenings 
Blisters: 
collection(s) of fluid 
under the epidermis 





of Scaly, Blisters, 




 Wounds:  An injury 
to any part of the 
tissues of the body 





Cut: Superficial and 
limited to the skin 
surface 
Gash: More than 
just skin surface 
affected up to the 
muscle layer 
 
Severe Gash: More 
than skin affected, 
muscle and/or 




Table 2.1. (cont.) 
 Scratching: To rub 
to alleviate itching 
utilizing nails or 
other objects 
No scratching or <1 
scratch per 30 
minutes 
Periodic: Scratches 
now and then >1 




occurring >1 time 
every 5 minutes or 
continuously for >1 
minute 
 
 Swelling Number: 
The number of 
swellings on the 
individual’s body 
None One: one swelling 
on the observed 
portion of the body 
Many: More than 
one swelling on the 





 Swelling Size: the 
size of any 
abnormal 
enlargement on any 
part of the body 
 
 Small: Little in size 
or extent (< 2.5 cm 
in diameter) 
Large: (> 2.5 cm in 
diameter) 
 Discharge: 
substance that is 
emitted or 
evacuated as a 
secretion 
 














effort in excreting 
feces from the 
rectum 
Same as moderate 
but continuous 
 Stool Color: color 
of the stool 
Brown Other: 
White/yellow, etc 
Black- dark colored 
stool possibly 
indicating blood 
from the upper GI 
tract 
Bloody Red: 
Reddish tinge or 
flecks of red in the 
feces indicating 
blood from the 
lower GI tract 
 
 Stool consistency: 
the degree of texture 
or viscosity of the 
feces 




Dry: harder than 
normal (lacking 
moisture or water) 
Other: a mixture of 
soft feces and hard 
ones or contains 
particulates 
Soft: No longer 
retains its normal 







Watery: stools no 





Table 2.1. (cont.) 
Other Signs: Signs 
other than what is 















 Prolapsed rectum Not observed Observed +/- 






 Vomiting Not observed Observed once 
 
Frequent vomiting 
 Dystocia Not observed Slow but 
progression made 
No progression and 
female exhausted 













Figure 2.1. An example of training materials used to define and demonstrate the 








Figure 2.2.  Screen capture of the electronic version of the IMPACT data collection 








Figure 2.3.  The IMPACT PDA program provides the observer with a complete list of 
known gorillas and gorilla groups in the Virunga Massif and Bwindi Impenetrable 





 a.  b. 
 
 
Figure 2.4.  Data entry for most items in the IMPACT data collection program is a 







Figure 2.5.  Screen capture of the main component of the IMPACT system which is a 








Figure 2.6.  Screen capture of the IMPACT web program showing that all 







Figure 2.7.  A monthly summary of normal and abnormal signs of the Nkuringo 
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Figure 2.8.  Home range calculation of the Nkuringo gorilla group based on 
observations conducted for health analysis from March 2002 to March 2003 (from 




Figure 2.9.  Visual display of cattle samples collected in Rwanda summer 2002 that 














































Figure 2.10. The proportional distribution of all gorilla observations by age group as 
compared to the distribution of individuals in the Nkuringo group in Bwindi 









CLINICAL RESPONSE DECISION TREE FOR THE MOUNTAIN GORILLA 




Disease is one of the main threats to the remaining great ape populations of 
the world. The decision to intervene in the health of individual great apes for 
population sustainability is controversial.  Humans’ increasing negative influence on 
great ape health has mandated the need to reevaluate the policies of current 
management practices.  The Mountain Gorilla Veterinary Project has been making 
health intervention decisions since 1986.  The decision to intervene has often been 
subjective due to poorly defined criteria often influenced by emotion.  This paper 
provides a consistent framework for evidence-based health intervention decision 
making.  The decision tree is a 5-tier process consisting of routine sentinel health 
observation, intensive follow-up veterinary health observation, outbreak assessment, 
risk assessment, and risk management.  Although the paper is based around the 





Great apes, the orangutans (Pongo pygmaeus) of Borneo and Sumatra, and the 
chimpanzees (Pan troglodytes), bonobos (Pan paniscus) and gorillas (Gorilla sp.) of 
Africa are facing uncertain futures with their long-term sustainability in question 
(Butynski 2001).  The most prominent threat to their survival is habitat 
destruction/fragmentation from logging and agricultural activities.  The second most 
serious threat relates to the development of roads associated with logging, allowing 
access and transport to and from remote areas providing an infrastructure for a 
commercial bush meat industry.  Disease is usually considered the third most serious 
threat, and has risen in public awareness due to the highly publicized outbreaks of 
Ebola virus in western Africa with resulting high mortalities in chimpanzees and 
gorillas (Morrell 1995).  In protected areas (i.e., conservation areas and national 
parks) where deforestation and bush meat practices are a lesser threat, disease is rated 
as the premiere threat.  
In 1997, the Population Habitat Viability Assessment held by the 
Conservation Breeding Specialist Group (CBSG) in Uganda, placed disease 
introduction as a major risk to the sustainability of the two populations of mountain 
gorillas (Gorilla beringei) in the protected areas of the Virunga Massif and Bwindi 
Impenetrable Forest (Werikhe et al 1997).  These parks have sharp boundaries 
between the forest and the human communities, with few existing buffer zones.  The 
human communities around the mountain gorilla parks have a density of between 
423-538 people/km2 (2002 Rwanda Census, Office National de la Population 
(ONAPO), Revue du Rwanda sur population et development, No 38, June 2003) and a 
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population growth rate of approximately 3.7%/year (Butynski 2001).  The mountain 
gorilla populations have the greatest percentage of human-habituated individuals of 
any ape species and are subjected to intense research and ecotourism programs.  
These factors, compounded by agricultural practices at the boundaries of the park, 
promote contact between gorillas, humans, and domestic animals, increasing the 
potential for the introduction and transmission of infectious diseases.  The health care 
within the human and domestic animal populations around the parks is less than 
optimal and poor sanitation exists.  Research has shown through genetic sequencing 
that the same enteric organisms (Giardia spp., Microsporidium spp. and 
Cryptosporidium spp.) are circulating amongst humans, cattle, and gorillas in and 
around the park (Nizeyi et. al. 1999, 2000, 2001).  The prevalence of antibiotic 
resistance to Enterococcus and E. coli in mountain gorillas has been found to be 
greater than expected for wild populations of animals and has a similar pattern to 
human and cattle antibiotic resistance in the Bwindi area (Byarugaba, D. Makrere 
University, unpublished data).  Gorillas share greater than 98% genetic similarity 
with humans (Hacia 2001) and are susceptible to many of the diseases of humans, 
including the zoonotic diseases associated with livestock.  
Opportunistic blood samples have shown that the gorillas lack antibodies and 
are probably naïve to many diseases endemic to other species the region (i.e., 
measles); these, if introduced into the gorillas, may cause high morbidity and 
mortality, thus making this a high risk population for a serious epidemic (Hastings 
1991, Nutter et al. 2005).  The Mountain Gorilla Veterinary Project (MGVP), 
supported by the Morris Animal Foundation, was formed in 1986 at the request of 
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Dian Fossey to provide emergency medicine and pathology services to the mountain 
gorilla population of Rwanda (Cranfield et. al. 2002).  Due to low numbers of gorillas 
in these populations and genetic studies showing that each animal's genetic input into 
the population's genome is important (Garner and Ryder 1996), the mountain gorillas 
are managed on an individual as well as a population basis with respect to veterinary 
care (Cranfield et. al. 2002). 
Veterinarians, trackers, guides, researchers and other personnel from MGVP, 
the Ugandan Wildlife Authority, Office Rwandais du Tourisme et des Parcs 
Nationaux, the Institut Congolais pour la Conservation de la Nature, Dian Fossey 
Gorilla Fund International and the Institute for Tropical Forest Conservation monitor 
the health of the gorilla populations.  Although health monitoring is done by 1) 
observation, 2) non-invasive biological sampling, and 3) post mortem examinations, 
the data has not been collected in a uniform fashion.  The collection of important 
baseline medical data from invasive sampling of live animals had been conducted on 
an infrequent, non-standardized opportunistic basis.  To better understand the basic 
epidemiology of diseases within the ecosystem and monitor gorilla health, a 
standardized method of data collection and analysis was developed and implemented.  
Any veterinary interaction (darting, treating, anesthetizing, etc) of a gorilla(s) 
is considered an intervention.  Interventions (with or without immobilization) are 
regulated by the protected area authorities and veterinarians and have occurred only 
in the presence of human-induced or life-threatening health problems.  This 
intervention policy has been ambiguous, often subjective, and emotional.  
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From a process designed to develop a contingency plan, a method to 
standardize data collection was created that included concerns of all stakeholders.  As 
a byproduct, this lead to the design of the clinical decision tree to standardize the 
intervention response to health-related issues.  This decision tree is helping to ensure 
standardized data collection, so that meaningful comparisons can be made to better 
assess risk and risk management options. In this chapter, the logic and structure of the 
clinical decision tree developed by MGVP is outlined with examples of how the 
system would function in relation to outbreak and non-outbreak situations. 
 
DEVELOPMENT 
The Mountain Gorilla Veterinary Project’s clinical response decision tree was 
created for 2 purposes.  The first purpose was to standardize protocols for risk 
assessment to aid veterinarians and managers in making objective evidence-based 
intervention decisions that are easily communicated and provide consistency in 
veterinary care between clinicians in the face of three different countries’ 
management systems. The second was to categorize risk and therefore, act as a trigger 
to commence the actions outlined in a previously developed contingency plan aimed 
at reducing the likelihood that a disease, once introduced, will cause a major outbreak 
or epidemic in the mountain gorilla population. 
The development of the decision tree process spanned 2 regional meetings of 
gorilla conservation organizations, which included non-governmental organizations 
(NGO’s) and the protected area managers of the Democratic Republic of Congo, 
Uganda, and Rwanda. The first iteration was created by several field and captive 
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primate veterinarians and veterinary and human epidemiologists.  After input and 
discussion by all stakeholders, it was edited by the Contingency Plan Team of 
MGVP.  This chapter provides a summary of the final product.  
To be useful and practical, the decision tree remains a dynamic document and 
is designed to be applicable for use in other, similar, wildlife situations.  Clinical 
decisions are reactionary in nature.  However, clinical signs considered normal in one 
animal can portend an outbreak in another situation.  A good decision process must 
help distinguish between these 2 situations and trigger a response only when 
necessary. 
In many cases, clinical interventions are based on the presence of clinical 
signs alone.  Because these are often non-specific, and therefore not associated with a 
definitive diagnosis, the severity of the observed signs may be the best indicator of 
risk for timely response. To address this issue, a severity index of clinical signs was 
created; terminology was standardized through the use of a data dictionary (Table 
3.1). 
A quality decision support tool utilizes analytical methods, such as decision 
analysis, optimization algorithms, and program scheduling routines for developing 
models to help decision makers formulate alternatives (Adelman 1992).  For the 
decision tool to function effectively, the expertise of the collective users (in this case 
wildlife veterinarians) must be captured in such a manner to fit into a decision 
algorithm.  This decision tree was developed in such a manner as to flow through a 




THE DECISION TREE PROCESS 
The decision tree process consists of 5 hierarchical levels that follow each 
other in succession (Figure 3.1);  
Level 1: Collection and review or routine sentinel health monitoring data by 
trackers, guides, and/or behavioral researchers using a basic standardized health 
observation form, either paper based or a specially programmed personal data 
assistant (PDA).   
Level 2: Intense follow-up observations by trained health personnel using a more 
complex form focused on abnormalities from the basic observation data with a 
more detailed level of review. 
Level 3: Outbreak assessment that places the scenario into either an outbreak or 
non-outbreak category by the prevalence of clinical signs or a definite diagnosis. 
Level 4:  Assessment and categorization of the outbreak into low, medium, or 
high risk at individual or population levels.  
Level 5: Risk management through implementation of the contingency plan. 
 
Level 1: Routine health monitoring and review 
Routine sentinel observational monitoring is the foundation of the health 
program for the mountain gorilla.  Individual animals are observed for abnormalities 
that may indicate a health problem. Routine health observation data is gathered either 
by the trackers and guides or researchers on either a paper form or a PDA.  Data is 
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downloaded into an internet-based data system, (produced by MGVP Database Team) 
called IMPACT™ (Internet-supported Management Program to Assist Conservation 
Technology).  A strict data dictionary (Table 3.1) in conjunction with thorough 
training ensures the consistency and accuracy of the data.  
Using the PDA, the observer identifies and enters the name of the group they 
are observing and the PDA automatically lists names of individual gorillas in the 
chosen group.  If the observer is using the paper form he/she picks the pre-made form 
that contains the names of the gorillas in the group being observed.  The observer 
then records whether an individual animal was or was not observed (Figure 3.2a).  If 
an animal is marked observed, the program asks which of the following parameters 
were observed A) body condition, B) activity, C) respiratory system, D) skin/hair, E) 
discharge from head orifices, F) discharge from other areas of the body, G) stool and 
H) other parameters (Table 3.1).  Each parameter is then recorded as normal or 
abnormal with the ability to enter a text description for each abnormality noted 
(Figure 3.2b).  
Paper collected data is entered into an internet interface, whereas PDA data can 
be directly uploaded into IMPACT.  Once data is uploaded, reports are automatically 
generated by IMPACT as in Figure 3.3.  If no abnormalities were reported on the 
observation, no further action would be indicated by the decision tree.  The observation 
data is used to compile normal prevalence rates of parameters observed (see Figure 3.1, 
Level 1).  Thus, IMPACT is a valuable tool for epidemiological evaluation of an 
outbreak in a uniform and statistically valid fashion.  In cases where Level 1 routine 
observations indicate abnormal systems (Figure 3.4), the tool will direct the 
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veterinarian or trained health personnel to complete Level 2, intensive follow-up 
observation, for complex data collection and review (see Figure 3.1, Level 2).  
 
Level 2: Intensive follow-up observation, with a more complex data collection and 
review 
The second level of data collected for input into the decision tree requires 
trained field health personnel to conduct a second observation of the group to confirm 
accuracy of basic data.  This evaluation uses a more detailed and complex paper form 
or PDA observation module in the IMPACT program.  This program is very similar 
in design, function and use to the basic level program, but when a parameter with an 
abnormality is entered (Figure 3.5a), a screen appears with a list of strictly defined 
clinical signs to describe the abnormality in greater detail (Table 3.1, Figure 3.5b).  If, 
as in the example of Figure 3.4, a routine basic observation report indicates 
abnormalities, and a subsequent intensive follow-up observation shows that the 
abnormalities are resolved (i.e., the animal stopped coughing and the wound is 
healing), no further action would be taken and data is stored in the database of 
epidemiological information.  If the intensive follow-up observation shows abnormal 
clinical signs, as in Figure 3.6, then the decision has to be made as to whether the 
abnormality should be considered a non-outbreak or outbreak situation (see Figure 






Level 3: Outbreak assessment 
An outbreak is defined as the occurrence of a disease or other health related 
event in excess of what would be expected for the specific region and period of time.  
Although an outbreak may be defined by a single case, the term often implies that 
several individuals are affected.  Important considerations in the investigation of an 
outbreak of infectious disease includes determining that an outbreak is, in fact, 
occurring and defining the extent of the population at risk.  Given that data gaps exist 
in knowledge of the baseline prevalence of clinical signs and diseases in the mountain 
gorilla, outbreak assessment may initially prove to be the most challenging task.  In 
the past, the identification of an outbreak was based on the collective experience and 
subjective judgment of the park manager and veterinarians.  Presently, outbreak 
definitions are defined by using past clinical observations and the new data being 
amassed by IMPACT, with the ability of the veterinarians and park managers to 
confirm or override the program at any point.  One benefit of this system is that 
IMPACT records and updates the prevalence rates of clinical parameters and signs 
spatially and temporally as it monitors for health.  Thus, observations on healthy and 
sick/injured animals allow continual refinement of estimates of “normal” prevalence 
rates.  This has been one of the faults of historical non-uniform health data collection 
where frequently only data from unhealthy animals were recorded.  
In Figure 3.4, if abnormal clinical signs are equal to or less than expected 
based on normal prevalence rates (i.e., the coughing resolved, but the cut turned out 
to be a snare) it is considered a non-outbreak situation (see Figure 3.1, Level 4) and 
the data are stored.  Non-outbreak assessments usually deal with individual welfare 
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issues.  If the prevalence of abnormal clinical signs is greater than expected, as we see 
in Figure 3.6, then the scenario would be assessed as an outbreak (see Figure 3.1, 
Level 4).  Outbreak risk assessment would more likely involve population welfare. 
 
Level 4: Risk assessment and categorization into low, medium or high risk 
Risk assessment is the process of estimating the implications of a 
disease/hazard introduction and results in a final estimate or characterization of the 
risk.  Risk assessment is a logical process by which risks are evaluated based on 
available scientific information.  This standardized format for risk assessment 
supports veterinarians to make evidence-based decisions in the field.  It also provides 
organization to vital communication efforts between field personnel, the park 
authority, veterinarians and other NGO-stakeholders.  For the process to work and 
ensure transparency, both the assumptions made and the factors contributing to 
certainty in estimates of risk must be fully elucidated and documented.  
The vast majority of the time in the field, risk assessment is based on 
observational/clinical signs due to the limited availability of quantitative information.  
Therefore, the assessment is primarily qualitative in nature.  Qualitative risk 
assessment, although not as desirable as quantitative assessment, has been recognized 
as a valid tool by the World Trade Organization, the Food and Agricultural 
Organization of the United Nations, and the Organization of International Epizootics.  
This decision tree must function in the stochastic world of veterinary medicine in a 
field situation.  It therefore, must deviate from decision mechanisms used in human 
medicine.  These deviations include dependency on observed clinical signs rather 
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than verbal communication for patient assessment, the risk and difficulties in 
performing routine physical exams on gorillas, and the necessity, in most cases, for 
anesthesia of the animal for sample collection and treatment.   Available human 
diagnostic tests may or may not be validated for gorillas, leading to their questionable 
diagnostic value.  The risk assessment decision tree process is initiated by qualitative 
data, but quantitative data should be collected for confirmation or to reduce 
uncertainty in the characterization of risk.  Over time IMPACT will acquire the 
quantitative data needed to help make the decisions more objective.   
Level 4A: Risk assessment for an outbreak scenario:  Risk assessment for an 
outbreak usually involves group or even population level decisions.  This paper 
presents two methods by which outbreak risk can be assessed.  The first method, 
disease diagnosis, is derived from clinical signs or diagnostic test results, (i.e., 
examples in Table 3.2).  The categories of low, medium and high risk are derived 
from data on morbidity and mortality rates from human medicine, experience with 
non-human primates in captivity, and limited disease experience from wild ape 
populations.  Table 3.2 updates occur as new information becomes available.  The 
second method, in cases where a definitive diagnosis cannot be made, incorporates a 
combination of clinical signs, postmortem examination results and estimated 
transmission and mortality rates (Table 3.3).  Data are analyzed by the IMPACT 
system and placed into risk categories and implementation strategies that are then 
confirmed by veterinarians.   Risk categories were compiled from past experiences by 
a team of experienced field and captive primate veterinarians, as well as veterinary 
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and human epidemiologists.  Table 3.3 is dynamic and will constantly be updated as 
IMPACT incorporates its own data into the decision tree. 
To make risk categorization consistent and functional, parameters and clinical 
signs were defined and ranked by severity (Table 3.1).  The rate of transmission is 
defined as low (0-1 new cases in >3 days), medium (1 new case every 2-3 days), and 
high (1 or more new cases per day). Mortality rates are defined the same as rates for 
transmission.   Prior to multiple observations when transmission and mortality rates 
can be calculated, the field veterinarian must rely on past experience to estimate these 
rates. 
Level 4B: Risk assessment for a non-outbreak scenario: The non-outbreak risk 
assessment usually involves decisions on an individual level rather than population 
level.  Clinical signs are characterized by the likelihood that they are infectious or 
non-infectious, as well as, the likely route of introduction.  If signs are human 
induced, life threatening and treatment is beneficial and practical, immediate 
intervention is warranted.   If the situation is non-human induced, whether infectious 
or non infectious, then the following decision making criteria are used: 
A) Low Risk: Not likely life-threatening and will probably resolve without 
treatment, 
B) Medium Risk: Potential to be life threatening and may need treatment, 
C) High Risk: Likely life-threatening and needs treatment.  
Because “natural” injuries and mildly abnormal clinical signs occur as part of 
the gorilla’s natural history, this non-outbreak intervention decision is still somewhat 
subjective and often relies on demographic information for decision making.  Once a 
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risk assessment and categorization is complete, risk management protocols should be 
implemented (Figure 3.1, Level 5).  
 
Level 5: Risk management  
The goal of risk management is to reduce implications or recurrence of an 
introduced hazard.  Risk management plans must be tailored to the situation but basic 
recommendations exist within the decision tree; risk management or implementation 
plans were developed for each risk category in both outbreak and non-outbreak 
situations (Figure 3.1, Level 5). 
Risk management actions in non-outbreak situations 
Low Risk Category Actions: 
1) Continued observation,  
2) Collection of non-invasive samples if deemed necessary,  
3) Reporting the problem to the Protected Area Authorities (PAA), the Host 
country wildlife Veterinary Authorities (HVA) and the MGVP Project 
Director (PD). 
Medium Risk Category Actions:  
1)   Review demographic information 
2)   Consider immobilization and collection of invasive samples,  
4)  Provide treatment or any beneficial preventive action, 
5) Communicate this to the PAA, HVA and PD,  




High Risk Category Actions:  
1) Review demographic information, 
2) Perform an immobilization for sample collection and treatment, 
3) Make sure that international export permits are ready to ship samples if 
necessary, 
4) Contact outside help if deemed desirable,  
5) Formulate a written action plan,  
6) Communicate this to the PAA, HVA and PD. 
Gorillas occasionally get their hands or feet accidentally caught in snares set 
to catch other animals.  They are generally strong enough to break these snares free 
from their grounding but are usually left with ropes or wires attached to their limbs.  
This is one example of a non-outbreak situation because it usually only involves one 
animal and there is no potential to transmit the problem to other gorillas.  The fact 
that snares are human induced, and often life-threatening, calls for immediate 
intervention. 
Risk management actions in outbreak situations 
Low Risk Category Actions: 
1) Continue to observe and assess for progression to moderate or high risk,   
2) Perform collection of non-invasive samples, 
3) Produce reports on MGVP response and observation to the PAA, HVA, 
and PD. 
Medium Risk Category Actions: 
1) Intensify observations to watch for advancement to high risk, 
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2) Perform immobilizations if deemed necessary for diagnostic invasive 
sample collection, 
3) Notify the PAA, HVA, PD, other appropriate stakeholders and public 
health officials, 
4) Prepare a formal report and written action plan on problem, and MGVP 
activities. 
High Risk Category Action:  
1) Perform intervention(s) for diagnostics and treatment,  
2) Assess new information and redefine plan if necessary,  
3) Obtain additional help from regional or international resources/experts,  
4) Put potentially necessary health resources on standby, 
5) Obtain international export permits and distribute written protocols for 
immobilizations, treatments and drug dosages, vaccinations and 
diagnostics to the invited health providers,  
6) Communicate to all appropriate people (PAA, HVA, PD, stakeholders and 
public health officials),  
7) In the face of an expansive and extreme outbreak the most extensive part 
of the contingency plan is implemented.  Where international veterinary 
assistance is necessary, other expertise such as epidemiologists, GIS 
experts and consultation with the Center for Disease Control and 






To illustrate the flow process of the decision tree, 4 scenarios have been 
established (Figures 3.3, 3.4, and 3.6).   In the first scenario (Figure 3.3), the level 1 
observation of the trackers and guides finds no abnormalities in any of the gorillas 
observed on that day.  The decision tree does not progress to the second level, but 
does integrate the information into the IMPACT database to enhance the decision 
power for detecting outbreaks.  In the second scenario, the level 1 observation does 
detect abnormalities in at least one gorilla (Figure 3.4).  Specifically, Kabatwa was 
detected with a cut on the wrist and Turiho was heard coughing, both abnormal signs 
by definition in the data dictionary (Table 3.1).  The decision tree will automatically 
flow from level 1 to level 2, requiring a more intensive follow-up observation by a 
veterinarian.  The data collected by the veterinarian will then determine the next flow 
path for the decision tree.  If the cut on the wrist is healing fine and the cough is no 
longer detected (i.e., both signs verified and determined negative), the data from both 
the level 1 or tracker and guide the day before and the level 2 or veterinarian follow-
up will be incorporated into the database.  Conversely, if the level 2 follow-up 
determines that either the cut on Kabatwa’s wrist or the cough is still abnormal, then 
the decision tree flows to level 3; the outbreak assessment.   
Ultimately, the system will determine outbreak vs. non-outbreak status using 
the data amassed with the IMPACT database.  The system will determine if levels of 
signs are greater than expected for that group, age class, and season.  Until enough 
data are available for this automated check, the outbreak assessment must be 
conducted based on past clinical experience of the field veterinarians and the 
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protected area managers.  In the example in Figure 3.6, a second gorilla (Guhonda) 
has been detected with the same clinical signs as Kabatwa the day before.  The 
veterinarians and protected area managers would determine this to be an outbreak 
situation.  Thus, the decision tree would flow to level 4, risk assessment in the 
outbreak pathway. 
The risk assessment of the severity of the outbreak is determined using the 
factors in Table 3.3.  The example in Figure 3.6 shows a scenario with greater than 
normal prevalence of abnormal clinical signs, or an outbreak situation of medium risk 
(Table 3.3) where the rate of transmission is high (≥1 new case/day) but the mortality 
rate is low (no mortality observed).   
Once the risk is categorized as a medium risk, the decision tree flows to level 
5, the risk management of an outbreak situation with medium risk.  The decision tree, 
under this situation, recommends the continued intensive monitoring of the group to 
determine changes in the number of cases or severity of clinical signs, either of which 
could push the situation into a high risk category.  Diagnostic sampling of the sick 
individuals should be considered.  Immobilization of Kabatwa and Guhonda should 
be considered a possibility if invasive samples are required (i.e., blood, etc.), or 
simply fecal and urine samples may need to be collected.  If samples are collected, 
export permits may be required to get samples to the appropriate laboratories in the 
U.S. or Europe.  Treatment for the 2 animals with an antibiotic also would be an 
alternative.  If the situation persists in a medium risk level, regional help from other 
parties may be required.  Either way, an action plan should be drafted in case there is 
need to immobilize or treat any of the gorillas.  Finally, the MGVP project director, 
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protected area manager, any local stakeholder groups and the public health officials 
should be informed of the outbreak situation. 
If on the other hand, the cough of Kabatwa resolves before the level 2 follow-
up but the cut on Turiho’s wrist is determined to be a snare, then the decision tree will 
assess the situation at level 3 as a non-outbreak and proceed to level 4 along the non-
outbreak path.  Because a snare is a human-induced situation, the risk automatically 
becomes high and an intervention for removal is required.  This pushes the decision 
tree to the 5th level, risk management.  Under this situation, no additional aid from 
outside sources would be required, nor are export permits for samples needed.  A 
situation report or action plan would be developed and shared with the MGVO 
project director and protected area manager. 
 
IMPLICATIONS 
One of the deficiencies of historical health data collection systems is that 
normally, only data from unhealthy animals was recorded.  One benefit of IMPACT 
is that it constantly incorporates new data, including that from normal, healthy 
individuals, and adjusts baseline prevalence rates accordingly, thus allowing for 
assessment of risk to be based on the most up-to-date information available for the 
population of concern. 
The design of this system has gone through multiple iterations.  As its 
development progressed, many aspects had to be simplified and definitions made 
clear and rigid to be practical.  The last major modification was to tier the observation 
format into two data collection forms, a basic form completed by trackers, guides and 
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researchers, and a complex form completed by health care professionals.  This 
alleviated the problem of trying to develop one form for all purposes and often failing 
to accomplish the intended goals. 
Another difficult aspect was developing standardized definitions for each 
clinical sign and the criteria to allow an observer to say they had seen enough of a 
parameter to call it normal.  We realized that perfect definitions do not exist under 
field conditions due to vegetation conditions and animal behavior and therefore, 
practical but productive definitions were agreed upon.  
An example of how the development of this system has changed clinical 
approaches is the response to respiratory outbreaks; particularly where multiple 
infants are involved.  Respiratory disease is responsible for approximately 25% of the 
mortality among examined corpses (Nutter et al. 2005).  Clinical respiratory 
outbreaks are common and usually pose the greatest risk to infants.  In the past, even 
if an infant died with respiratory signs and other gorillas were showing similar signs, 
the dead infant would be left until the mother abandoned it; eliminating the ability to 
perform a diagnostic post mortem examination.  Now if an infant dies with suspicious 
signs of infectious disease and/or other animals are showing signs of clinical illness, 
the mother is anesthetized, examined, sampled, and sometimes treated, while the dead 
infant is recovered for a thorough post mortem examination.  Other animals are often 
treated as appropriate, based on the finding of the post mortem examination and 
diagnostic samples from the mother.   
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Although the system has helped standardize the decision to intervene, there 
are still times that human emotion will override the process, such as when a gorilla 
received treatment for a naturally occurring wound to the eyelid, causing an unsightly 
appearance.  This situation should not have warranted an intervention and the wound 
should have been left to heal naturally.  Authorities, however, requested an 
intervention to avoid public criticism and the procedure was successfully completed. 
The clinical response decision tree combines data collection methods with a 
novel internet based risk analysis system (a part of IMPACT’s function) to direct 
implementation of action.  With slight modifications, the system also is being used 
with a wild chimpanzee population and could be modified for use for other wildlife 
populations. 
In conclusion, this tool is helping to encourage quick, well-informed, 
consistent, rational decision making.  The observational data portion of IMPACT will 
get more powerful as the observation database builds with ongoing use of the system.  
When coupled with a larger contingency plan that includes logistical support for field 
activities, public relations and ecotourism activities, it can be a powerful tool for the 
conservation of this irreplaceable natural resource.  It is my hope that the experience 
and knowledge gained by MGVP and its partners in the development of this process 
will aid other great ape conservationists in their endeavors.  The clinical response 
decision tree was the product of a multidisciplinary group of veterinarians, 
epidemiologists, and public health professionals with input and consensus from the 
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Table 3.1. The data dictionary of the clinical parameters and signs with severity 
ratings for the clinical decision tree of the Mountain Gorilla Veterinary Project. 
 
  Severity Rating 






Body Condition: the 







terms of muscle 
mass and body fat 
Unable to see the 
ribs and muscles 
appear normal 
Thin: a) estimated 
<10% loss of weight 
b) able to see the 
ribs 
c) notable muscle 
atrophy 
Very thin: a) >10% 
loss of body weight 
b) ribs obviously 
pronounced 




 Abdomen: part of 
the body that lies 
between the thorax 
and the pelvis 
Abdomen extends 








sunken and concave 
Activity: Quality of 
being active 
General Attitude: 
The manner of 
acting 
Age and sex 
specific appropriate 
behaviors 
Behavior not like 
rest of the members 
at a particular time 
of day or in a 
particular context. 




behaviors in the 
context of the 
environment. e.g. 
still in the nest after 
9 am or at one spot 
> 1 hour with no 
body manipulation 
 
 Manipulation: Any 
manual movement 




of the limbs of the 
body 
Unable to perform 
normal movements 
of any part(s) of one 
or more limbs 
Unable to perform 
normal movements 
of any part(s) of 
one or more limbs, 
high degree of 
dysfunction present 
 
 Movement: The act 
of passing the whole 
body from place to 
place 
Normal movement 
of the whole body 
Lameness: 
Abnormal 
movement of one or 
more limbs leading 
to the individual 
limping 
Severe Lameness: 
unable to keep up 
with the group, 
abnormal 




to respiration which 







as no. of 
breathes/minute 
When the observer 
visualizes the 
nostrils and the 
chest and the animal 
appears comfortable 
and you barely 
visualize  the 
movement of the 
chest and there are 






Slow: Breathing  
observed as <15 
breathes/minute and 
audible sounds 
may/may not be 
heard 
Fast: When 
breathing is >25 
/minute with/ 
without audible 




Table 3.1. (cont.) 
 Breathing difficulty: 



















 Coughing quality: 
Coughing is sudden 
explosive forcing of 
air through the 
glottis & larynx 
 
No coughing Dry: Harsh, grating, 






 Coughing pattern: 
The sequence of 
coughing 
Doesn't interrupt the 




interruption of the 
individuals 
activities due to 
coughing 
Continuous: 
Coughing >1 time 




 Sneezing: Expelling 
air from the nose 












of sneezing that are 
isolated events with 




episode of sneezing 




and all of their 




Skin and Hair: The 
tough membranous 
tissue that forms the 
external covering of 
the individual and 




Skin and hair as 




pieces of epidermis 
sloughing off the 
body  
Loss of hair: 





ulcers , erosions 
pustules, nodules 
maculae, scars, and 
thickenings 
Blisters: 
collection(s) of fluid 
under the epidermis 





of Scaly, Blisters, 




 Wounds:  An injury 
to any part of the 
tissues of the body 





Cut: Superficial and 
limited to the skin 
surface 
Gash: More than 
just skin surface 
affected up to the 
muscle layer 
 
Severe Gash: More 
than skin affected, 
muscle and/or 




Table 3.1. (cont.) 
 Scratching: To rub 
to alleviate itching 
utilizing nails or 
other objects 
No scratching or <1 
scratch per 30 
minutes 
Periodic: Scratches 
now and then >1 




occurring >1 time 
every 5 minutes or 
continuously for >1 
minute 
 
 Swelling Number: 
The number of 
swellings on the 
individual’s body 
None One: one swelling 
on the observed 
portion of the body 
Many: More than 
one swelling on the 





 Swelling Size: the 
size of any 
abnormal 
enlargement on any 
part of the body 
 
 Small: Little in size 
or extent (< 2.5 cm 
in diameter) 
Large: (> 2.5 cm in 
diameter) 
 Discharge: 
substance that is 
emitted or 
evacuated as a 
secretion 
 














effort in excreting 
feces from the 
rectum 
Same as moderate 
but continuous 
 Stool Color: color 
of the stool 
Brown Other: 
White/yellow, etc 
Black- dark colored 
stool possibly 
indicating blood 
from the upper GI 
tract 
Bloody Red: 
Reddish tinge or 
flecks of red in the 
feces indicating 
blood from the 
lower GI tract 
 
 Stool consistency: 
the degree of texture 
or viscosity of the 
feces 




Dry: harder than 
normal (lacking 
moisture or water) 
Other: a mixture of 
soft feces and hard 
ones or contains 
particulates 
Soft: No longer 
retains its normal 







Watery: stools no 





Table 3.1. (cont.) 
Other Signs: Signs 
other than what is 















 Prolapsed rectum Not observed Observed +/- 






 Vomiting Not observed Observed once 
 
Frequent vomiting 
 Dystocia Not observed Slow but 
progression made 
No progression and 
female exhausted 




 Table 3.2. Risk assessment for the Mountain Gorilla Veterinary Project clinical 




Disease Morbidity Mortality Impact on 
 in great apes in great apes Humans 
    
High Risk    
Ebola High High High 
Other hemorrhagic fevers High High High 
Encephalomyocarditis High High Medium 
Rabies Low High High 
Polio High High High 
Shigella High High Low 
Mycobacterium tuberculosis  High High High 
Mycobacterium bovis High High High 
Measles High High Low 
Strep pneumonia High High Medium 
    
Medium Risk    
Entamoeba histolytica Medium Low Medium 
Rotavirus Low Low Medium 
Respiratory syncytial virus  High Low Medium 
Monkeypox High Low Medium 
    
Low Risk    
Parainfluenza High Low Low 
Coronavirus Low Low Low 
Salmonella Low Low Low 
Campylobacter Low Low Low 
Sarcoptes Medium Low Low 
Entamoeba coli Medium Low Low 
Microsporum Medium Low Low 




Table 3.3. Outbreak risk assessment for the Mountain Gorilla Veterinary Project 
clinical decision tree by Clinical Signs. 
 
Risk Category Description 
  
Low 1 dead with no clinical signs of infectious disease and no other animals 
with clinical signs of infectious disease 
 1 dead with no clinical signs of infectious disease and 1 or more 
individuals with mild or moderate clinical signs of infectious disease 
 No dead and mild or moderate clinical signs in ≤ 8 or ½ of the group size 
 1 or more individual with infectious disease with an estimated low 
transmission rate and low mortality rate 
  
Medium 1 dead with clinical signs of infectious disease 
 No dead and severe clinical signs in 1-3 animals 
 No dead and combination of moderate and/or severe clinical signs in 2-4 
animals 
 No dead and mild to moderate clinical signs in ≥ 8 individuals in a group 
or ½ of the group size 
 1 or more individuals with clinical signs of infectious disease with an 
estimated low transmission rate but medium to high mortality rate 
 1 or more individuals with clinical signs of infectious disease with an 
estimated medium to high transmission rate and low mortality rate 
 Combination of clinical signs never before observed regardless of severity 
  
High >1 dead with clinical signs of infectious disease 
 No dead and severe clinical signs in >3 animals 
 No dead and a combination of moderate or severe clinical signs in >4 
animals 
 ≥1 dead and severe clinical signs in >1 animal 
 ≥1 dead with a combination of mild to moderate clinical signs in ≥8 
individuals or ½ the group size 
 ≥1 gorilla with signs of an infectious disease and an estimated medium to 
high transmission rate and medium to high mortality 
 An infant with severe clinical signs with a mother that has mild to 
moderate clinical signs 




Figure 3.1. Flow chart of the clinical response decision tree for Mountain Gorillas 
(Gorilla beringei). N/A = not applicable, +/- = decision on individual case basis, reg 
= regional or in-country veterinarians can handle situation, inter = international help 
needed, PA = protected area authority, PD = MGVP project director, PH = Public 
health official, SH = stakeholders, S = Subsequent groups, Approp Inst = Appropriate 




 a.    b. 
 
Figure 3.2.  Screen capture of the IMPACT personal data assistant data collection 
basic observation program showing a) a list of individuals found in the observed 
group, and b) the observation of an individual gorilla asking which parameters were 




Your data have been uploaded into IMPACT and analyzed 
 
Date of observation(s): 02/02/04 
Group Observed: Sabyinyo 
 
Number of individuals in the group observed: 9 or 100% 
Number of individuals in the group not observed: 0 or 0% 
Total group size: 9 
 
Number of dead gorillas observed: 0 
Number of non-group members observed: 0 
Total number of individuals observed: 9 
 
Number of abnormal parameters: 0 
Number of individual gorillas with abnormal parameters: 0 
Number of new abnormal parameters since yesterday: 0 
     2-3 days: 0 
     last week: 0 
 
TRACKER AND GUIDE DETAILED SUMMARY 
Number of abnormalities by parameter: 
PARAMETERS   NORMALS   ABNORMALS 
Body Condition    9    0 
Activity     9    0 
Respiratory     4    0 
Skin/Hair     4    0 
Discharge – Head    2    0 
Discharge – Other    0    0 
Stool       0    0 
Other System     0    0 
 
Individuals observed with abnormalities: 0 
NAME    PARAMETER(S) ABNORMAL 




GORILLA    COMMENTS 
None      None 
ACTION TO BE TAKEN:                            None  
 
Figure 3.3.  Example IMPACT summary report from a Level 1 routine observation 





Your data have been uploaded into IMPACT and analyzed 
 
Date of observation(s): 02/02/04 
Group Observed: Sabyinyo 
 
Number of individuals in the group observed: 9 or 100% 
Number of individuals in the group not observed: 0 or 0% 
Total group size: 9 
 
Number of dead gorillas observed: 0 
Number of non-group members observed: 0 
Total number of individuals observed: 9 
 
Number of abnormal parameters: 2 
Number of individual gorillas with abnormal parameters: 2 
Number of new abnormal parameters since yesterday: 2 
     2-3 days: 2 
     last week: 2 
TRACKER AND GUIDE DETAILED SUMMARY 
Number of abnormalities by parameters: 
PARAMETERS   NORMALS   ABNORMALS 
Body Condition    9    0 
Activity     9    0 
Respiratory     4    1 
Skin/Hair     4    1 
Discharge – Head    2    0 
Discharge – Other    0    0 
Stool       0    0 
Other System     0    0 
 
Individuals observed with abnormalities: 
NAME    PARAMETER(S) ABNORMAL 
Kabatwa    Respiratory 




GORILLA    COMMENTS 
Kabatwa    Coughing a lot 
Turiho     Cut on left wrist 
 
ACTION TO BE TAKEN:  Conduct intensified observation and more complex data 
collection and review. 
 
Figure 3.4. Example IMPACT summary report for a Level 1 routine observation with 
abnormal parameters. 
 
 a.    b. 
 
Figure 3.5.  Screen capture of the IMPACT personal data assistant data collection 
intensive observation program showing a) the observation of an individual gorilla 
asking which parameters were seen and if they were normal or abnormal, and b) the 




Your data have been uploaded into IMPACT and analyzed 
 
Date of observation(s): 04/02/04 
Group Observed: Sabyinyo 
 
Number of individuals in the group observed: 9 or 100% 
Number of individuals in the group not observed: 0 or 0% 
Total group size: 9 
 
Number of dead gorillas observed: 0 
Number of dead gorillas with clinical signs of infection: 0 
Number of dead gorillas without clinical signs of infection: 0 
Number of non-group members observed: 0 
Total number of individuals observed: 9 
 
Number of abnormal clinical signs: 5 
Number of individual gorillas with abnormal clinical signs: 3 
 
Number of mild or moderate abnormalities: 5 
Number of mild or moderate infectious abnormalities: 2 
Number of mild or moderate noninfectious abnormalities: 1 
Number of mild or moderate undetermined (+/-) abnormalities: 2 
 
Number of severe abnormalities: 0 
Number of severe infectious abnormalities: 0 
Number of severe noninfectious abnormalities: 0 
Number of severe undetermined (+/-) abnormalities: 0 
 
Number of new abnormal clinical signs since yesterday: 1 
   2-3 days: 2 
   last week: 3 
Number of new mild or moderate abnormalities since yesterday: 1 
   2-3 days: 2 
   last week: 3 
Number of new severe abnormalities since yesterday: 0 
   2-3 days: 0 
   last week: 0 
Estimated Transmission Rate for this group is HIGH 
Estimated Mortality Rate for this group is LOW 
 
 
Figure 3.6. Example IMPACT summary report from a level 2 intensified observation 
as a follow-up to the routine observation of Sabinyo group (Figure 3.4) where two 
individuals were observed with abnormal parameters that have not resolved, and 
additional cases were observed thereby indicating an outbreak situation. 
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THIS GROUP IS PROBABLY IN AN OUTBREAK 
IF IT IS IN AN OUTBREAK THE RISK LEVEL FOR THIS GROUP IS MEDIUM 
Action to be taken:  Continue Observation, Alert Protected Area Manager and Project 
Director 
 
VETERINARIAN DETAILED SUMMARY 
Number of abnormalities by parameter: 
 
PARAMETER NORMAL  MILD or MODERATE 
 SEVERE 
Body Condition      9    0        0 
Activity       9    0            0 
Respiratory       7    2        0 
Skin/Hair       8    1        0 
Discharge – Head      7    2        0 
Discharge – Other      9    0        0 
Stool         2    0        0 
Other System       0    0        0 
 
Individuals observed with abnormalities: 
NAME   PARAMETER (S) ABNORMAL 
Turiho   Skin/Hair 
Guhonda  Respiratory, Discharge - Head 




GORILLA   COMMENTS 
Turiho    Wound healing well, using hand normally 
Guhonda   Continuous productive coughing 
Kabatwa   Continuous productive coughing 
 











A syndromic surveillance system was developed by the Mountain Gorilla 
Veterinary Project (MGVP) to collect standardized data on a consistent basis to 
understand the ecology of disease within this highly endangered species.  The system 
is based on a hierarchical decision tree where trackers and guides observe animals 
daily for abnormalities.  When abnormalities are observed, MGVP veterinarians 
verify any abnormalities using standard clinical signs.  The decision tree is predicated 
on the assumption that the trackers and guides and the veterinarians can conduct 
observations in the same standard fashion.  This study demonstrates that the 
percentage of a group observed on any observation varies with group size and 
whether a veterinarian or tracker and guide conducted the observation.  The 
probability of observing any individual gorilla varies with the size of the group, 
observer type and gender/age class of the individual.  Adult and subadult females, 
juveniles, and subadult males tend to be observed less than expected, whereas adult 
males (silverbacks) and infants tend to be observed more than expected. When 
individual gorillas are observed, the 7 parameters used to assess gorilla health vary 
with observer type.  This indicates that training for both the veterinarians and trackers 
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and guides conducting observations needs to be provided to adjust observation habits.  
The data suggest that the reactionary observation of the veterinarians to problems 
detected by the trackers and guides may bias their observation to specific gender/age 
classes and reduce the number of individuals seen.  It is recommended that longer 
observation periods be conducted, the validity and reliability of the observation be 
verified, and that trackers and guides conduct observations on the same day as 
veterinarians to obtain the most complete information.  This paper provides the first 
attempt to evaluate a syndromic surveillance system to monitor health of mountain 
gorillas to identify emerging threats. 
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INTRODUCTION 
Mountain gorillas (Gorilla beringei beringei) are a highly endangered sub-
species of great apes.  The range of mountain gorillas is confined within Rwanda, 
Democratic Republic of Congo and Uganda (Butynski and Kalina 1993).  It has been 
recognized from experiences with great apes in captivity and limited data from wild 
populations that the potential introduction of diseases from the human population and 
domestic animals to the mountain gorilla is one of the greatest threats to their long-
term viability.  Gorillas share >97% of their genetic make-up with humans (Sibley 
and Ahlquist 1984, Hacia 2001), making them susceptible to many diseases from 
humans (Butynski and Kalina 1998).  Due to conservation practices and the growing 
eco-tourism, many groups of free ranging gorillas have been habituated to humans 
(Butynski et al. 1990, Butynski and Kalina 1993).  The increase in interactions 
between the gorillas and man can facilitate transfer of anthropozoonotic pathogens 
(Ashford, et al. 1990, Ashford, et al. 1996, Hastings, et al. 1992, and Mwebe 1998), 
which can lead to occurrence of disease. 
The popularity of tourism has brought enormous international interest to the 
gorillas.  This same eco-tourism innovation that has been used to protect the gorillas 
has led to increased gorilla exposure to people from all over the world, bringing 
potential carriers of diseases within sneezing distance of the gorillas on a daily basis.  
Yet, so little is known about the risks this has created for these unique animals 
(Butynski and Kalina 1998).  Disease is one of the factors that could lead to a 
population crash (Butynski 1990).  In protected areas (i.e., conservation areas and 
 94
national parks) where deforestation and bush meat practices are a lesser threat, disease is 
rated as the number one threat to mountain gorilla survival.  
Currently, the Mountain Gorilla Veterinary Project (MGVP) and 
governmental conservation veterinarians monitor the health of the gorilla populations 
by observation, non-invasive biological sampling, and post-mortem examination.  
Access to biological samples is limited to invasive collection during interventions for 
life-threatening problems and available archived material.  Because of this limitation 
of physical contact with the animals, an intervention policy using clinical signs 
obtained during routine observation was developed (Chapter 3, MGVP Decision Tree 
Writing Group In Press).  
The clinical decision tree was conceptualized with input from various 
stakeholders including field staff.  It outlines how a health and/or management action 
is triggered through the identification and assessment of the number and severity of 
clinical parameters and signs (Chapter 3, MGVP Decision Tree Writing Group In 
Press).  The foundation of the decision tree is daily clinical observations.  Daily 
clinical observations record whether the individual gorillas were observed or not, and 
the observation of normality and abnormality within 7 different designated body 
parameters.  The system was piloted by MGVP veterinarians (Rwego 2004) to ensure 
that clinical parameters and signs could be observed in the wild.  Daily clinical 
observations are currently restricted to one hour, the time allotment for a tourist 
visitation.  The decision tree is multi-tiered, with the base tier being the daily 
observations of trackers and guides.  The second tier is a more comprehensive 
observation by veterinarians when the opportunity arises and an individual gorilla is 
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deemed in need of medical examination.  The overall objective of this study was to 
evaluate select elements of the clinical decision tree of MGVP to determine the 
overall effectiveness for monitoring gorilla health using this multi-tiered approach.   
 
METHODS 
The clinical signs were recorded on a form developed by Mountain Gorilla 
Veterinary Project (MGVP) with input from other Non-Governmental Organizations 
(NGO) and Protected Area managers at an International Gorilla Conservation 
Program (IGCP) regional meeting. The definitions for clinical parameters and signs 
used in this study are taken from the MGVP decision tree writing group (2005) 
(Chapter 3).  An electronic version of the data form was created for use on Personal 
Data Assistants (PDA). 
The All Occurrence Sampling method was used (Martin and Bateson 1998) to 
record any clinical parameters observed in all the gorillas in the group.  Observing all 
the gorillas isn’t always possible during the one hour visitation period, though as 
many as possible are observed during this period of time.  During the visitation 
period, the gorillas seen and not seen are noted, and clinical parameters observed 
(body condition, activity, respiration, integument (skin/hair), discharge from the head, 
discharge other, and stool) and their status (normal/abnormal) recorded.  In All 
Occurrences Sampling (AOS) method the occurrence or non-occurrence of certain 
types of easily observed behaviors are for every individual observed (Martin and 
Bateson 1998). 
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The number of individuals observed was documented to provide the 
denominator for estimation of prevalence rates.  The number of individuals observed 
is compared to the entire group to determine how representative observed individuals 
are in terms of age and gender distribution relative to the entire group.  Age groups 
were defined as infant, juvenile, subadult, and adult.  Gender classes could not be 
determined for infant and juvenile. 
Data collection commenced when the observer visiting the gorillas first 
encountered the gorilla group.  After the day-specific data were recorded (e.g., 
number and type of people viewing the gorillas, altitude, location, time of day, etc) 
the observer would locate and identify individual gorillas and begin recording 
specific data.  For each gorilla, 7 parameters were chosen for observation (Table 3.1).  
All parameters were strictly defined in a data dictionary (MGVP Clinical Decision 
Tree Group In Press, Table 3.1).  The observer recorded which parameters and/or 
signs they adequately observed for that individual gorilla.  
The clinical decision tree is a multi-tiered system with observations being 
conducted by trackers and guides or veterinarians (MGVP Clinical Decision Tree 
Group In Press, Chapter 3).  Therefore, some observations in the system are 
conducted at the tracker/guide level, whereas others are at the veterinarian level.  The 
main difference between the two observations is the level of detail observed.  The 
designated leader of the trackers and guides observe individual gorillas to the level of 
the parameter (i.e., body condition, respiratory, skin/hair, etc.), whereas the 
veterinarians provide detail to the clinical sign level (sunken abdomen in body 
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condition, hair loss in skin/hair, etc.).  Although the phrase “trackers and guides” is 
used, it denotes a single individual from this group conducting an observation.  
Extensive training on the identification, classification, and recording of 
clinical signs was conducted with the trackers and guides to ensure consistency in 
observation data.  The field veterinarians were trained as a group by long-term field 
veterinarians and researchers with extensive field experience.  These field 
veterinarians were then used to train the trackers and guides within their respective 
regions. Standardized training materials were developed for use in all training 
sessions. 
Individual gorillas were recorded as seen and then, any parameters seen were 
recorded. As individual gorillas are often mobile during the observation period, an 
individual would be followed so that the observer could attempt to complete an 
observation (defined as observing all listed parameters); whereas at other times, 
depending on how practical it was to follow the gorillas, the observer remained 
stationary and recorded information on gorillas as they passed in and out of sight.  
Thus, during an observation period, individual animals were either seen or not, and if 
seen, clinical parameters and signs of each individual were observed or not.  Of 
interest is the detection rate of individuals, as well as, the observability of each 
clinical sign, given the animal was observed. 
Detection rates were modeled as a logistic regression using a logit link 
function in SAS (SAS Institute, Inc., version 9.1) Proc GLIMMIX and Proc 
GENMOD.  Type of observer (tracker and guide/veterinarian) and gender/age class of 
gorilla were treated as fixed effects and group and individual were modeled as 
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random effects.  Chi-square contingency tables were used to discern differences 
among levels within main effects of the logistic model.  Pearson correlations were 




Two hundred twenty three observations were obtained on mountain gorilla 
groups from 2002-2005.  Observations were conducted in Bwindi Impenetrable 
Forest National Park in Uganda (n= 210) and Parc de National de Virungas in 
Rwanda (n= 13).  Ten different gorilla groups were observed during this study (Table 
4.1).  Numbers of total observations per group during the study period ranged from 1 
to 121.  A total of 132 different gorillas were observed.  Veterinarians conducted 99 
observations, while trackers and guides 124.  Observations were approximately one 
hour in duration.  
The average group size for observed gorilla groups was 17.1 individuals, with 
a range of 6 to 38.25 (Table 4.1).  During an average observation, 65.5% of the 
individuals in a group were observed (Table 4.1).  The proportion of the group 
observed was influenced by group size (χ21 = 98.98, P<0.001) and whether the 
observer was a veterinarian or tracker/guide (χ21 = 35.30, P<0.001).  The model 
parameter estimates indicated that trackers and guides saw more of the group during 
an observation than did the veterinarians and the proportion of the group observed 
declined with group size (Table 4.2, Figure 4.1).  The rate of decline was greater in 
veterinarians than in trackers and guides (χ21 = 10.10, P<0.001).  A chi-square 
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analysis corroborated that trackers and guides observed more individuals per 
observation than did veterinarians (χ21 = 247.7, P<0.001).   
Group size (F1,3033 = 10.27, P=0.0014), gender/age class (F6,3033 = 3.46, 
P=0.0020), and observer type (F1,3033 = 10.33, P=0.0013) main effects all influenced 
the probability of an individual being observed.  A significant interaction was 
observed between gender/age class and observer type (F4,3033 =7.64, P<0.001).  The 
model parameter estimates indicated that trackers and guides are more likely to 
observe an individual than a veterinarian and that observability of an individual 
decreases with group size.  Plots of the probability of observing an individual of a 
gender/age class by either a veterinarian (Figure 4.2a) or a tracker/guide (Figure 4.2b) 
illustrate the different observation probabilities between the two groups.   The range 
of variation in observability increased dramatically as group size increased (Figure 
4.3). 
Across all observers, juveniles, adult and subadult females, and subadult 
males were observed less than expected, whereas adult males and infants were 
observed more than expected (χ26 =247.8, P<0.001).  Within the observations of 
trackers and guides, both adult males and females were seen more than expected, 
whereas juveniles and subadults were seen less than expected (χ25 =122.5, P<0.001).  
Within the observations of the veterinarians, adult and subadult females were 
observed less than expected, whereas adult and subadult males were observed more 
than expected (χ25 =140.9, P<0.001). 
For those animals that were observed, the observability of the parameter body 
condition was influenced by whether the observer was a veterinarian or tracker/guide 
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(F1,1751 = 48.48, P<0.001) (Figure 4.4).  Body condition was observed less often by 
the veterinarians than the trackers and guides.  Trackers and guides observed the body 
condition of adult males and infants more than expected whereas they observed adult 
female body condition less than expected (χ25 =25.621, P<0.001).  Veterinarians did 
not show observation bias to any gender/age class on body condition (χ25 =2.952, 
P=0.707).  Although graphically it seems that infants are observed less frequently 
than the other groups, the variation around estimates are very large (Figure 4.5).   
The observability of the parameter of activity was not influenced by group 
size or gender/age class of the individual, but was influenced by observer type (F1,1748 
=13.28, P=0.0003) (Figure 4.6).  Trackers and guides (χ25 =10.376, P=0.065) and 
veterinarians (χ25 =1.706, P=0.888) did not show observation bias to any gender/age 
class on the activity parameter.  Although graphically veterinarians appear to observe 
infants less often than other gender/age classes, the variability around the estimates 
are large and estimates, therefore, not different (Figure 4.7). 
The observability of the parameter of respiration was not influenced by group 
size (F1,1746 = 1.12, P=0.2910), gender/age class (F6,1746 = 0.70, P=0.6491) or observer 
type (F1,1746 = 0.60, P=0.4393)(Figure 4.8).  The parameter was observed slightly 
more often by the veterinarians than the trackers and guides.  Examined alone, 
trackers and guides observed the respiratory parameter more often than expected in 
adult males and infants, but less often in the other gender/age classes (χ25 =11.427, 
P=0.040).  Veterinarians did not show observation bias to any gender/age class on 
respiration (χ25 =4.748, P=0.447); however, infants and adult females are predicted to 
be observed least often (Figure 4.8). 
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The observation of the integument parameter did not vary with group size 
(F1,1691 =0.42, P=0.5180), the type of observation (F1,1691 =1.46, P=0.2267), or the 
gender/age class of the individual (F6,1691 =1.83, P=0.090) (Figure 4.9).  Although the 
range of observability of the integument parameter was limited, the model predicts 
veterinarians to observe infants consistently less often than the other gender/age 
classes (Figure 4.9), though the differences are not significant (Figure 4.10). 
The observation of discharge from the head was influenced by the observation 
type (F1,1751 =31.06, P<0.0001).  The parameter was observed more often by 
veterinarians than trackers and guides, with tracker and guide observability dropping 
off more sharply at larger groups sizes (Figure 4.11).  The range of variability in 
tracker and guide observations increased as group size increased (Figure 4.13).  
Trackers and guides observed adult females, infants, and adult males more than 
expected while juveniles and subadult males were observed less than expected (χ25 
=20.065, P=0.001).  Veterinarians did not show observation bias to any gender/age 
class on discharge from the head (χ25 =6.157, P=0.291). 
Due to the limited number of observations of the parameter, the random 
effects of individuals within group could not be included in the model of discharge 
from parts other than the head (discharge other, henceforth).  Because of this, the 
interaction of observer type with gender/age class could not be examined. Trackers 
and guides were more likely to observe the parameter of discharge-other than 
veterinarians (F1,1752 = 83.22, P<0.001) (Figure 4.13).  Gender/age class did not effect 
observability of discharge-other (F6,1752 = 0.71, P=0.6440) (Figure 4.14). Trackers and 
guides observed this parameter more than expected on adult males and less than 
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expected on all other gender/age classes (χ25 =26.434, P<0.001).  When veterinarians 
did observe this parameter, they did not show bias to any gender/age class (χ25 
=4.463, P=0.483). 
Due to the limited number of observations of the parameter of stool, the 
random effects of individuals within group could not be included in the model.  
Because of this, the interaction of observer type with gender/age class could not be 
examined.  The observation of the stool parameter was influenced by the observer 
type (F1,1752 =11.90, P<0.001) and gender/age class of the individual (F6,1752 =12.32, 
P<0.001).  Trackers and guides were more likely to observe this parameter than 
veterinarians (Figure 4.15).  Adult males were more likely to be observed whereas 
infants less likely (Figure 4.16).  Care must be taken in interpretation of this estimate, 
however, even though the model did converge, the goodness of fit criterion of 
deviance indicate that the model may not be adequate (value/df = 0.50).   Trackers 
and guides observed adult male stool more than expected and infants, juveniles, and 
adult females less than expected (χ25 =88.670, P<0.001); whereas veterinarians did 
not show observer bias to any gender/age class (χ25 =4.567, P=0.471). 
 
DISCUSSION  
The syndromic surveillance system is predicated on the assumption that 
individual gorillas within groups and clinical signs are equally observable across 
groups and individuals.   This study indicated that attributes of the individual gorilla, 
the gorilla group, and the observer influenced observability of individuals and clinic 
signs.  During this study, percentage of the group observed was influenced by group 
 103
size and type of observer.  As the group size increased, the limitation of a one hour 
observation made it more difficult to adequately observe each of the gorillas for 
overall health.  Figure 4.1 indicates that a group size of 20-25 individuals would only 
have about ½ of the group observed.  Thus, a longer time period may be required for 
veterinarians and trackers and guides to make an adequate observation on the whole 
group.   
Trackers and guides differed from veterinarians in their ability to observe the 
entire group.  It is not unexpected that the trackers and guides would observe more 
individuals in a single observation compared to veterinarians.  The veterinarians are 
often conducting observations to verify some abnormality identified by the trackers 
and guides the previous day.  Thus, the veterinarians are more focused on observing 
an individual gorilla rather than observing the entire group.  Additionally, the 
veterinarians are not as familiar with the individuals as the trackers and guides and 
may require assistance for identification purposes.  Finally, the veterinarians are 
conducting more detailed observation using the complex form. All of these factors 
hinder the veterinarian’s ability to observe the same number of individuals as the 
trackers and guides.  Another possible explanation is that trackers and guides are 
overestimating the number of individuals they observe.  It might be recommended 
that the trackers and guides conduct an observation on the same day as the 
veterinarian to maintain the greatest amount of information for the group.   
Group size, the type of observer, and gender/age class of the individual 
significantly affected the observability of an individual gorilla.  This can have 
significant ramifications for a syndromic surveillance system.  Adult and subadult 
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females tended to be observed less than expected across all observations.  In a 
population with such low numbers as the mountain gorilla, the female and infant 
portion of the population becomes especially important.  The current methodology of 
conducting an observation may cause this discrepancy in observation of these classes 
of individuals as adult females tend to be more secretive, especially when they have 
new born infants.   
When examined by observer type, the trackers and guides tended to under 
observe the juveniles and subadults.  Thus, it is the veterinarian observation that 
under observes the female population.  This points to the need for a more structured 
approach to conducting an observation.  Watts (1996) determined that mountain 
gorillas maintain a social structure that influences the distribution of the group in 
space.  He noted that adult females and young tended to be more closely associated 
with the adult males for protection.  Thus, the observations of the trackers and guides 
tend to follow this pattern of gender/age class distribution.  By entering the “center” 
of the group around the adult male, they observe the gender/age classes most closely 
guarded. 
Differences in observability may also impact ecotourism by what gender/age 
classes tourists are able to see.  If adult females with infants are less visible, does this 
affect the tourists’ attitudes of seeing the gorillas?  Researchers may be interested in 
determining the expectations of tourists to provide customer satisfaction. 
The probability of observing the 7 parameters of body condition, activity, 
respiration, integument, discharge from the head, discharge other, and stool that are 
used as the measures of animal health varied mostly by observer type.  The 
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probability of observing the parameters body condition, activity, respiration, 
integument, and discharge from the head across group size, were observed on average 
50% of the time or more regardless of the observer type (Figures 4.4, 4.6, 4.8, and 
4.11, respectively).  If observing half of the individuals during an average observation 
is acceptable, then any statistical difference attributed to differences of observer type 
would be negligible. The respiration and discharge from the head parameters, 
however, were predicted to decline precipitously at larger group sizes (Figures 4.8 
and 4.11).  Because respiratory diseases are one of the most common problems in the 
gorillas (Nutter et. al. 2005) and this parameter points to signs of respiratory 
problems, observers may need to be encouraged to watch more closely for this 
parameter. 
Within the tracker and guide observations, the gender/age classes were often 
observed disproportionately more than expected.  Veterinarians tended to show little 
bias towards gender/age classes in an observation.  Trackers and guides tended to 
observe the discharge head more than expected in infants, adult females and adult 
males.  Similarly, trackers and guides tended to observe the respiratory parameter 
more than expected in infants and adult males.   From a health standpoint, respiratory 
diseases are one of the leading causes of mortality in infants (Nutter et. al. 2005).  
The fact that the trackers and guides over observed these parameters in the infant 
population is encouraging.  However, the respiratory parameter of adult females is 
still observed less than expected and several parameters are observed seldom at larger 
group sizes.  The training of the trackers and guides is standardized to the extent 
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possible, however, it may need to be stressed during the training to be more diligent 
on the observation of some parameters. 
This study assumes that there is validity and reliability in the observations 
under consideration.  A study is currently underway with MGVP, the Uganda 
Wildlife Authority, and the Wildlife and Animal Research and Management Unit at 
Makerere University to assess validity and reliability of the clinical decision tree.  
The study will aid in determining the quality and consistency of the tracker and guide 
data in terms of ability to detect individuals, observability of each of the parameters, 
and correspondence to the observation of a veterinarian and other trackers and guides. 
In sum, results from this study indicate that longer time periods are needed for 
observations.  Additionally, there appears to be differences in the observations 
conducted by veterinarians versus the trackers and guides.  This may be a function of 
the reactionary nature of the veterinarians to an abnormality detected by the trackers 
and guides.  The veterinarians are specifically looking for a single gorilla to examine 
some health issue, while the trackers and guides are conducting a general survey of 
the group, irrespective of an individual abnormality.  It may be necessary for trackers 
and guides to conduct observations even on the days that veterinarians collect data.  
This would provide consistent data with previous observations and a more complete 
assessment of the entire group for that day. 
No assessment of the observation of abnormalities could be conducted at this 
time.  Currently, none of the tracker and guide observations indicated any 
abnormalities in the gorillas.  The validity study currently underway should determine 
if any disparities in detection of abnormalities between trackers and guides and 
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veterinarians exist.  Additionally, data will need to be collected during an outbreak 
situation to determine any associations between the 7 parameters and disease.  Once 
the clinical decision tree is validated, a year of data collection is needed to establish 
the first annual baseline of information for the gorillas.  This dataset will allow us to 
develop seasonal epidemiological profiles of parameters for the species.  It is 
recommended to revisit the issues raised in this study after modifications to the 
system are implemented.  This first attempt to use and test a syndromic surveillance 
system on mountain gorillas as an indicator of health demonstrates proof of concept 
but also identifies sources of variability and opportunities to improve disease 
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Table 4.1. Mountain gorilla groups observed in Rwanda and Uganda, 2002-2005, 
with the average group size and mean, minimum, and maximum percentage of group 
observed during each observation. 
 










Amahoro 1 70.4 77.8 66.7 13.0
13 3 30.8 30.8 30.8 9.0
H 1 83.3 83.3 83.3 6.0
Habinyanja 15 54.8 100.0 22.7 22.0
Kyagurilo 36 93.3 100.0 42.9 14.0
Mubale 21 91.1 100.0 50.0 8.0
Nkuringo 121 56.5 90.5 21.1 19.2
Rushegura 18 79.9 100.0 61.5 13.0
Sabinyo 4 84.1 100.0 72.7 11.0
Susa 4 33.8 50.0 13.2 38.3
     





Table 4.2. General linear model of the percentage of a mountain gorilla group seen 
during a one hour observation in relationship to group size and whether the observer 
was a veterinarian or tracker/guide.   
 
Parameter DF Estimate Upper 95% CI Lower 95% CI 
Intercept 1 1.2137 1.1188 1.3086 
Group Size 1 -0.0280 -0.0335 -0.0225 
Observer Typea 1 -0.4885 -0.6496 -0.3273 
Size*Observer 1 0.0143 0.0055 0.0231 

































Figure 4.1.  Predicted proportion of a mountain gorilla group observed during a one 
hour clinical observation by veterinarians and trackers and guides of Rwanda and 




































































Figure 4.2.  Predicted probability of an individual mountain gorilla of a specific 
gender/age class being observed by (a) veterinarians or (b) trackers and guides in 




























































Figure 4.3.  Variability of predicted observation of an individual mountain gorilla of 
the most and least observed gender/age class by (a) veterinarians or (b) trackers and 










































































Figure 4.4.  Predicted probability of the body condition being observed in a mountain 
gorilla by (a) veterinarians or (b) trackers and guides in Rwanda and Uganda (note 










































































Figure 4.5.  Variability of predicted observation of the body parameter on a mountain 
gorilla of the most and least observed gender/age class by (a) veterinarians or (b) 














































































Figure 4.6.  Predicted probability of the activity parameter being observed in a 
mountain gorilla by (a) veterinarians or (b) trackers and guides in Rwanda and 



































































Figure 4.7.  Variability of predicted observation of the activity parameter on a 
mountain gorilla of the most and least observed gender/age class by (a) veterinarians 











































































Figure 4.8.  Predicted probability of the respiration parameter of a mountain gorilla of 
a specific gender/age class being observed by (a) veterinarians or (b) trackers and 















































































Figure 4.9.  Predicted probability of the integument parameter of a mountain gorilla 
of a specific gender/age class being observed by (a) veterinarians or (b) trackers and 








































































Figure 4.10.  Variability of predicted observation of the integument or skin/hair 
parameter on a mountain gorilla of the most and least observed gender/age class by 
(a) veterinarians or (b) trackers and guides in Rwanda and Uganda. F=female, 
























































































Figure 4.11.  Predicted probability of the parameter of discharge from the head for a 
mountain gorilla of a specific gender/age class being observed by (a) veterinarians or 












































































Figure 4.12.  Variability of predicted observation of the parameter of discharge from 
the head for a mountain gorilla of the most and least observed gender/age class by (a) 






































Figure 4.13.  Predicted probability of the parameter of discharge from parts other than 
the head for a mountain gorilla being observed by veterinarians or trackers and guides 











































Figure 4.14.  Predicted probability of the parameter of discharge from parts other than 
the head for a mountain gorilla of a specific gender/age class being observed in 

































Figure 4.15.  Predicted probability of the parameter of stool for a mountain gorilla 

































Figure 4.16.  Predicted probability of the parameter of stool for a mountain gorilla of 
a specific gender/age class being observed by (a) veterinarians or (b) trackers and 









ASSESSMENT OF PATHOGENS WITHIN THE VIRUNGA MASSIF AND 
BWINDI IMPENETRABLE FOREST NATIONAL PARK ECOSYSTEMS 
 
ABSTRACT 
The transmission of pathogens from one species to another is common place 
throughout the world.  More often than not, the transmission is determined to go from 
wildlife to domestic species.  In some circumstances, however, the reverse is true.  
For a highly endangered species such as the mountain gorilla, disease transmission 
can be devastating to the entire population.  This study examines the pathogen loads 
and distributions of species within and surrounding the 2 national parks in Central 
Africa that are home to the mountain gorilla.  A total of 2492 fecal samples were 
extracted from the IMPACT health information system monitoring program.  One 
thousand seven hundred and ninety six humans, 149 domestic cattle, 248 baboon, 63 
rodent, 114 gorilla, and 122 chimpanzee fecal samples were available for analysis.  
Of these, 1000 humans, 149 cattle, 140 baboon, and 11 gorilla samples were spatially 
referenced.  A total of 17 different pathogens were detected within the samples.  
Humans had the highest pathogen load with 13 species, followed by cattle and 
chimpanzees (11), baboon (10), gorillas (9), and rodents (3).  The average number of 
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pathogens detected for individuals within each species ranged from 0.13 in rodents to 
3.59 in humans.  The moment of k for all pathogens was < 1, indicating a relatively 
balanced ecosystem.  Cryptosporidium, Giardia, and Trichuris in humans were 
spatially aggregated, however, the identical spatial distribution of positive values for 
Cryptosporidium and Giardia lead the author to question the validity of lab tests.  
With the high pathogen load in humans and the potential interaction with the gorillas, 
conservationists need to examine the impacts that local people might have on the 
species.  This research used existing data from multiple studies for analysis.  A well 




The transmission of disease from wildlife to domestic animals and humans is 
well documented around the world.  In the United States, bison (Bison bison) transmit 
Brucellosis to cattle (Meyer and Meagher 1995), armadillo (Dasypus novemcintus) 
harbor the leprosy bacilli (Truman 2005), and mice carry Hanta virus (Mills et. al. 
1999).  In Europe, badgers (Meles meles) carry Mycobacterium bovis (Phillips et. al. 
2003) and fox rabies (Pastoret and Brochier 1999).  In Asia, waterfowl can carry 
avian influenza (Martin et. al. 2006).  In Africa, many of the native livestock have 
been documented to be the source for Foot and Mouth disease (Vosloo et. al. 2002), 
Rinderpest (Kimber et. al. 2002), and Heartwater (Neitz 1935); and bats are possibly 
sources of the Ebola virus (Leroy et. al. 2005).   
In all of these cases, the direction of transmission is from wildlife to domestic 
animals.  However, disease transmission is not always one direction.  Domestic 
animals also can introduce disease to wildlife (e.g., Schmitt et. al. 1997, Nielsen et. al. 
2000), although frequency is thought to be relatively rare.  The issue of disease at the 
domestic animal and wildlife interface has become a topic of great concern world 
wide (see Gibbs and Bokma 2002). 
The mountain gorilla (Gorilla beringei) is one of the most endangered species 
in the world.  The estimated 740 remaining gorillas occur in two populations in the 
protected areas of the Virunga Massif and Bwindi Impenetrable Forest National Park 
(Werikhe and Miller 1998).  In these protected areas, disease has been determined to be 
the greatest threat to the species survival (CBSG 1997).  Within the ecosystem of the 
mountain gorilla, genetic research has shown that the same species of enteric organisms 
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(Giardia spp., Microsporidium spp. and Cryptosporidium spp.) are circulating amongst 
humans, cattle, and gorillas (Nizeyi et al. 1999, 2000, 2002). 
The human population on the African continent has seen a dramatic increase 
since the era of colonization (Kock et. al. 2002).  The country of Rwanda has one of the 
highest densities on earth with an estimated 423-538 people/km2 (2002 Rwanda Census, 
Office National de la Population (ONAPO), Revue du Rwanda sur population et 
development, No 38, June 2003).  With this burgeoning of people on the continent, 
there has been a corresponding increase in the amount of domestic animals also 
present (Kock et. al. 2002).  This high population of human and domestic livestock 
has pushed up to the very borders of the protected areas for the mountain gorillas.   
Because of this sharp edge of human and domestic animal activity to the natural 
vegetation of the park, there is increased potential for contact with gorillas.  In some 
areas, gorillas are frequently seen outside the park.  Rwego (2004) documented that 
nearly half of all observations on the Nkuringo gorilla group were outside the 
boundaries of the Bwindi Impenetrable Forest National Park.  This occurrence of 
gorillas outside of the protected areas increases the potential for disease transmission 
among these 3 groups. 
One way to assess this transmission potential is by using spatial mapping and 
analysis.  The objective of spatial mapping and analysis in epidemiology is to 
understand the relation between the pathogen of interest, the animal host(s), and the 
environment (Koch 2005).  Because pathogens and hosts interact within an 
environment, understanding their relationship requires understanding the 
environment.  The idea is that by identifying elements of the relationship, the 
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intrusion of dangerous pathogens can be controlled or limited by altering the element 
(Done 1985).   
Mapping of disease refers to a way of thinking that is inherently ecological.  
Mapping assigns relationships between multiple datasets in a manner that permits 
these datasets to be considered together in a spatio-temporal context.  The cognitive 
process of mapping encourages a perspective that is relational and spatial all at once.  
Mapping permits us to organize spatial events at scales that best facilitate an 
understanding of the phenomena chosen for study.  The outcome is an interpretation 
of events, of spatial relationships between selected aspects of a dynamic ecology 
(Koch 2005). 
Gibson et. al. (2002) stated that “overall disease burden is primarily a function 
of demography.”  While he was referring to the human population and its interactions 
with the environment, the same also may be stated for wildlife and domestic animals.  
Demography is also a geographic element.  Therefore, thinking about disease and 
health, we need to simultaneously consider the demographic and ecologic parameters 
of the host and pathogen communities and how they interact. 
Diseases in wildlife are generally distributed in a negative binomial fashion 
(Wilson et. al. 2004).  This distribution is an evolutionary trait for long-term 
persistence of the pathogen and host species.  A negative binomial distribution 
indicates that a few of the host species harbors the largest percentage of the pathogen 
population.  This association is usually termed aggregation.  Pathogens in wildlife are 
usually highly aggregated within the host population (Shaw and Dobson 1995).  The 
distribution of those few infected individuals within the host population is often the 
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question of interest.  Similarly, if the pathogen is not distributed in a negative 
binomial distribution, this is an indication of an imbalance in the pathogen-host 
relationship.  This imbalance can reflect an outbreak going through a natural cycle, or 
a perturbation of the system attributable to any number of ecological disturbances 
(Munson and Karesh 2002). 
Mapping uses classes of discrete events (individuals with disease or sign X) in 
the context of potentially relevant data (location, exposure, age, gender) in an attempt 
to demonstrate some type of relationship.  When events are aggregated at specific 
scales (park, group home range, nation) in association with related classes of data 
(group interactions, wildlife/domestic interactions, environmental overlap) a 
graphically demonstrable conclusion forms that suggests potential critical control 
points.  The power of mapping is derived from its approach in which location is a 
principal attribute of the characterization of events.  It is also a graphical way of 
thinking that assumes the basic bidirectional thinking of association (Wood 2003).  If 
events cluster around another object, then the object may have influence on the events 
(e.g., John Snow and the water pump).  This phenomenon is often referred to as 
“structural coupling” (Maturana and Varela 1992).  
The objectives of this study were to examine the relationships among the 
pathogens harbored by the gorillas, cattle, humans, and other wildlife in the Virunga 
Massif and Bwindi Impenetrable Forest National Park, and the potential implications 





Fecal samples and test results were extracted from the health information 
system monitoring program IMPACT™ (MGVP, Inc. http://mgvp.cfr.msstate.edu).  
Most human and cattle samples had associated GPS locational information, whereas 
the gorilla samples were associated with specific groups whose daily locations were 
georeferenced.  Sample observations were imported into the geographic information 
system ArcGIS (version 9.1 ESRI Inc, Redlands California) for analysis.  Attached to 
each sample location were the test results for fecal analysis.   
The aggregation of pathogens within each species was estimated by the 
corrected estimate of the moment k (Elliot 1977).  For this research aggregation is 
defined as the distribution of the pathogen load (number of pathogens/individual) 
within the host population or sample (Wilson et. al. 2004).  The moment k was 
calculated as: 
k = (m2-s2/n)/(s2-m) 
Where  m = sample mean 
 s2 = sample variance 
 n= number of samples 
Pathogen loads were plotted to examine their frequency distribution.  
Pathogens occur in a balanced pathogen host relationship as a negative bionomial 
distribution (Shaw and Dobson 1995).  Additionally, spatial plots were examined for 
clustering of pathogens within an area.  Clustering in this research is defined as the 
spatial pattern of distribution of samples that are positive for a pathogen (Shaw and 
Dobson 1995).  
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Sample distribution did not allow for the examination of spatial overlap of 
species to the gorillas within any area.  Similarly, the limited number of gorilla 
samples prevented identification of any interactions among other species.  Spatial 
clustering was examined for human and cattle samples collected around the Virunga 
Massif (Volcanoes National Park) in Rwanda using the Getis-Ord general G (Fortin 
and Dale 2005). 
 
RESULTS 
A total of 2492 samples were extracted from the IMPACT program (Table 
5.1).  One thousand seven hundred and ninety six humans, 149 domestic cattle, 248 
baboon (Papio hamadryas), 63 rodent, 114 gorilla, and 122 chimpanzee (Pan 
troglodytes) samples were available for analysis.  Of these, 1000 humans, 149 cattle, 
140 baboon, and 11 gorilla samples were spatially referenced (Figures 5.1 and 5.2).  
A total of 17 pathogens or pathogen classes were entered into the IMPACT 
system.  Humans had the most pathogens identified with 13 different listed (Table 
5.1).  Cattle and chimpanzees had 11, baboons 10, gorillas 9, and rodents 3.  The 
average number of pathogens detected for individuals within each species ranged 
from 0.13 in rodents to 3.59 in humans (Table 5.1).  Most pathogens detected in each 
species were either shared or had potential to be shared with other species.  Several of 
the pathogens were identified at the genus, class or super class level, not at the 
species level.  Prevalence rates of individual pathogens ranged from 0 to 88.4% 
(Table 5.2), with humans having consistently greater prevalence rates than the other 
species. Gorillas had a high prevalence of the tapeworm Anoplocephalis (88.4%), and 
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the roundworm Trichostrongyloid (57.9%).   Humans had relatively high prevalence 
of Ascarids (63.9%), Trichostrongyloids (54.7%), Nematodirus (41.0%), Trichuris 
(69.6%), Cryptosporidium (29.5%), and Giardia (30.6%).  Cattle were high in 
Eimeria (93.2%), whereas baboons were high in Ascarids (56.0%), Eimeria (59.7%), 
Strongyloides (26.2%), and Strongyloidea (31.5%).  Chimpanzees had relatively low 
prevalence in all organisms, as did the rodents. 
The moment k was calculated for all fecal samples for each pathogen 
detected.  Samples extracted from the system had results presented in several formats.  
Some of the samples had results reported in eggs/gram of sample, whereas others 
were listed as low, medium or high.  Sample results for humans (Figure 5.3), gorillas 
(Figure 5.4), and cattle (Figure 5.5) that were reported in eggs/gram were compared.  
The moment of k for all pathogens were < 1, as would be expected for a balanced 
ecosystem (Figures 5.3-5.5)(Shaw and Dobson 1995).  Sample results that were 
reported with the ordinal results also were compared.  The moment of k was <1, 
indicating a negative binomial distribution amongst all the pathogens for all species 
with ordinal data (Figures 5.6 – 5.11).  The moment of k was < 1 for all ordinally 
classified pathogen data (Table 5.3).   
The spatial distribution of pathogens within the humans was examined using 
the Getis-Ord general G (Fortin and Dale 2005) (Table 5.1).  Cryptosporidium and 
Giardia were highly clustered in distribution (Gi=0.004, z=16.7, P<0.01 for both) 
(Figures 5.12 and 5.13).  Both species had exactly the same pattern of distribution 
and, subsequently same clustering statistics, calling the results into question.  
Trichuris was also clustered in distribution (Gi=0.002, z=2.2, P=0.03) (Figure 5.14).  
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All other pathogens in humans were distributed in a spatially random pattern (Table 
5.4, Figure 5.15).  All pathogens in cattle surrounding the Virunga Massif in Rwanda 
were distributed in a spatially random pattern (Table 5.4, Figure 5.16). 
 
DISCUSSION 
This study used a series of fecal samples that were collected over a period of 
time and across several different research projects.  These samples and subsequent test 
results were entered into the IMPACT health monitoring system.  Information on 
distribution of pathogens among individual hosts and across space was extracted and 
examined in an attempt to get a better understanding of the distribution and flow of 
pathogens within the mountain gorilla ecosystem.   
This research found the infection rates of Cryptosporidium and Giardia in cattle 
around the 2 gorilla parks to be 12.8 and 16.1%, respectively.  This corresponds to the 
findings of Nizeyi et. al. (2002) who found prevalence rates of 38% for Cryptosporidium 
and 10% for Giardia.   Graczyk et al. (2002), found prevalence rates of 2, 5, and 10% 
for Giardia in gorillas, humans, and cattle surrounding the Bwindi Impenetrable Forest 
National Park in Uganda.  These are much less than the 9.1, 30.6, and 16.1% found in 
this study.  Research by Sleeman et. al. (2000) on parasite loads found in mountain 
gorilla in Rwanda more closely associates with the findings in this study.  They found 
Trichostrongyloides in 97.3% of all gorillas sampled.  Prevalence rates of Strongyloides, 
Trichuris, and Anoplocephalis were 1.4, 2.7, and 85.1%, respectively.  The findings of 
this study showed rates of infection at 57.9, 6.1, 113.4, and 88.4% for 
Trichostrongyloides, Strongyloides, Trichuris, and Anaplocephalis in the mountain 
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gorillas.  Ashford et. al. (1996) found prevalence rates of 98, 16, and 89% for 
Strongyles, Strongyloides, and Anaplocephalis, respectively, in gorillas in Uganda. 
The high numbers of pathogens and high prevalence rates in the humans 
sampled within the mountain gorilla ecosystem is alarming.  This is especially of 
concern when given the number of potentially zoonotic diseases observed.  With 
disease transmission to the gorillas being one of the greatest concerns for their long-
term survival (CBSG 1997), conservationists need to examine the impacts that local 
people are having or can have on the species.  Often the concern for gorilla health 
focuses on the tourists from outside the region who are visiting the gorillas.  Although 
this is still a major concern, focusing on the local human population also may be very 
beneficial to gorilla health.  MGVP maintains an employee health program that provides 
medical treatment to all personnel who work with the gorilla tourism program 
(Mountain Gorilla Veterinary Project 2002 Employee Health Group 2004).  Although 
annual antihelmenthic treatment is provided to all personnel working with the gorillas, 
the high prevalence within the general human population may override the once annual 
treatment provided.   
It is important to note that many of the pathogens listed within the IMPACT 
system are not entered at the species level.  Whereas the results indicate that pathogens 
are the same within groupings such as strongyloides, these are not classified to the 
species level.  Many pathogens (at the species level) are host specific.  This also points 
to limitations of data entered into a system like IMPACT.  The hierarchical level of 
classification of pathogens must be considered when using data from this type of 
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system.  The system may need to require entry of results to a specific taxonomic level of 
classification in the future to aid inter-species comparisons.  
Cattle are often regarded as the responsible host for the transfer of water borne 
pathogens such as Cryptosporidium and Giardia.  In this ecosystem, the cattle do not 
occur at the headwaters of the ecosystem.  The gorilla parks are based around the 
volcanoes, and therefore are upstream of any domestic cattle.  The transfer to the gorillas 
has to be from either gorillas leaving the park and using water sources that cattle use, or 
humans or other species are transferring the organisms into the park.  It is a well 
enforced regulation that all human defecation in the forest be buried. 
The very highly clumped distribution of the Cryptosporidium and Giardia and 
the identical distributions of the 2 organisms, leads this author to question the validity of 
lab results for these two pathogens.  Although the distribution for 2 water borne 
pathogens could be similar, the clustering of all positives in two areas of the country 
with no positives elsewhere is disconcerting.   There are 4 possible explanations to this 
clumped distribution; 1) the pathogen is truly distributed in this fashion, 2) the samples 
were contaminated upon collection, 3) the samples were contaminated after collection 
and shipping to the United States, and 4) the laboratory conducting the testing provided 
erroneous results.  Based on the distributions of other pathogens in the region and the 
poor sanitation and water conditions, this author feels the first explanation is not valid.  
Thus, conclusions based on the spatial distribution analysis of the Cryptosporidium and 
Giardia should be examined with scrutiny.  As this research was conducted on existing 
sample data and test results, this points to the limitation of such an analysis.  A research 
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study should be conducted to test the clustered distribution of these organisms, or the 
samples should be re-examined if they still exist.  
The highly aggregated distribution of samples within the species is a sign of a 
relatively healthy association with the host and pathogen (Hudson et. al. 2004).  
Pathogens that are spread across a large number of hosts are an indicator of an outbreak 
or other system imbalance.  The imbalance can be from the introduction of a new 
susceptible host with no immunity (or conversely, a new pathogen that local hosts are 
naïve to), artificial compaction of a host species, or reduced health condition in the host 
species.  The fact that nearly all pathogens were highly aggregated is a good sign for the 
gorillas.  
Aggregation in the host is one aspect of clustering, but pathogens also can 
cluster spatially.  A combination of aggregated and spatially clustered data points to a 
source location for a pathogen and a possible control point to reduce or eliminate the 
pathogen.  Nearly all the pathogens were not spatially clustered.  Only the whipworm 
Trichuris was aggregated and spatially clustered (ignoring Cryptosporidium and Giardia 
due to the potential problems listed above).  Whipworms are fecal-oral transmitted 
pathogens that can live asymptomatically in mammals for many years.  This study 
indicates that further investigation would be required, if Trichuris is a potentially 
harmful pathogen to the gorillas, to determine the potential for control.   
The observations extracted from the IMPACT system had many problems.  
First, most samples had no spatial information by which to georeference their 
collection site.  Of the 2492 samples from the system, only 1300 were able to be 
analyzed in a spatial context.  Those 1300 samples were not well distributed across 
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the landscape.  The samples were fairly clumped and may prevent the detection of 
clumped distributions of pathogens on a larger scale.  The samples extracted also 
were not consistent in the spatial referencing system used.  Most of the data were 
collected in the Universal Transverse Mercator Projection and World Geodetic 
System of 1984 datum.  Some 398 of the samples were collected in an unknown 
projection and datum and the remaining had no spatial information at all.  This points 
to the importance of the development of standardized data collection.  The IMPACT 
system developed for health monitoring for the mountain gorillas encourages the use 
of standard spatial data referencing for all samples collected. 
The samples in the system had varying degrees of information related to test 
results.  Whereas these were all fecal samples, several different tests were conducted 
on them depending on the original study objective.  Immunoflourescent assays were 
conducted on most of the samples to detect Cryptosporidium and Giardia species.  
All other parasites were detected using floatation and sedimentation techniques.  A 
number of the samples had been tested a second time with the floatation, once using a 
sugar floatation solution the second a salt solution.  The results for the sugar solution 
were used for this analysis due to discrepancies in the salt solution results.  The initial 
tests were conducted by the same institution and individual that conducted the IFA 
for Cryptosporidium and Giardia.  Additionally, visual examination of the data 
indicated the second testing provided results that are more similar to results obtained 
within country on similar animals (Alecia Lily, Dian Fossey Gorilla Fund 
International, unpublished data).  Because the data from the salt solution tests and the 
IFA show such unusual patterns, this researcher calls to question the validity of these 
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results.  Because of this, the results from the sugar solution retest are used for the 
analysis. 
With all of these problems, it was still a very worthwhile venture to conduct 
this study.  The results from this examination of existing data provide insights into 
potential problems for the gorillas.  The high prevalence rates of pathogens in the 
humans and moderate rates in cattle and baboon point to potential critical control 
points for disease transmission.  Social behavior in the different primates might 
provide clues to pathogen flow.   
The analysis also provided insights into short comings of how great ape health 
data are currently being collected and entered into such a system for analysis.  The 
clumped distribution of samples, the lack of sampling within the same area for 
multiple species, especially species that overlap with the gorillas, and the limited 
sample sizes for the gorillas all were weak points in the study.  This does, however, 
provide researchers with better understanding of what samples should be examined in 
the future.  Similarly, at least one species of interest in the gorilla ecosystem was 
conspicuously absent.  The forest buffalo (Syncerus caffer nanus) roams the forests of 
the parks and is often seen in association with domestic cattle.  This species is a prime 
vessel for the transport of pathogens into the protected areas.  
This research points to the need to conduct well designed scientific studies to 
examine pathogen distribution and flow patterns.  This analysis can provide for 
development of hypotheses, but the strength of analysis is limited.  A study that can 
provide greater insight into pathogen flow between species could be set up such that 
samples are collected for each of the gorilla groups on a weekly basis for a 1 year 
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time period.  The gorillas create new night nests for sleeping every night.  Upon 
waking and leaving the nest, they tend to urinate and defecate in the nest.  Silverbacks 
can be identified by the silver colored hairs, nest size, etc.  Thus, known individual 
silverbacks can be collected.  Additional samples of unknown but unique individuals 
also can be collected.  This would provide an annual baseline of pathogen load for 
known individuals (silverbacks) and groups.  To supplement this, weekly samples for 
known cattle and humans within the region surrounding the gorilla groups would 
provide a comparative assessment.  Finally, collection of samples of forest buffalo, 
baboon, and any other pertinent wildlife species in the home ranges of the gorilla 
groups would give a complete picture of pathogens and pathogen flow within the 
ecosystem. 
The IMPACT system was developed to collect and integrate health data on the 
species within the gorilla ecosystem and will help address many of the issues faced in 
this study.  Data will be collected in a standardized manner with spatial referencing 
information attached to the samples.  Laboratories will provide test results in more 
standardized formats for comparison with other labs.  There will still be a need to 
develop sound research projects to answer specific questions, such as the issue of 
Cryptosporidium and Giardia and their distribution.  Study designs should 
incorporate all aspects of spatial distribution sampling designs such as sample size, 
spatial extent, spatial grain, sampling strategy (i.e. random, stratified, systematic, etc.) 
and spatial lag of samples.   
The IMPACT system allows for exploratory analysis of data to develop more 
research hypotheses and provide more information on how to maintain the valuable 
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resource of the mountain gorilla.  The system urges individuals to collect data in a 
standardized format for comparisons across, as well as, within study projects.  
Because disease threats are considered premier to the existence of the mountain 
gorilla, studies such as this provide insight into the possible ecological processes that 
impact the long-term viability of this valuable wildlife resource.
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Table 5.1.  Pathogen loads detected within fecal samples collected within and 
around the Virunga Massif and Bwindi Impenetrable Forest National Park in 
Rwanda and Uganda. 
 




SE # Shared 
Pathogens* 
Gorilla 114 9 2.07 0.07 9 
Humans 1796 13 3.59 0.06 12 
Cattle 149 11 2.17 0.09 9 
Baboon 248 10 2.18 0.09 10 
Chimpanzee 122 11 0.48 0.06 11 
Rodent 63 3 0.13 0.05 3 
 
* Identification was not always to the species level. Pathogens identified only to the 
genus or family level may be different species.
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Table 5.2. Prevalence (% of samples positive) of pathogens found within fecal 
samples collected within and around the Virunga Massif and Bwindi Impenetrable 
Forest National Park in Rwanda and Uganda. 
 
Pathogen Gorilla Human Cattle Baboon Chimpanzee Rodent 
Ascaris 0.0 63.9 19.6 56.0 10.7 0.0 
Trichostrongyloides 57.9 54.7 15.2 0.0 0.0 0.0 
Nematodirus 28.7 41.0 4.7 0.0 0.0 0.0 
Strongyloides 6.1 5.8 19.6 26.2 10.7 0.0 
Strongyloidea 15.9 0.6 0.7 31.5 5.7 0.0 
Trichuris 13.4 69.6 12.8 13.3 5.7 0.0 
Eimeria Sp. 0.0 0.0 93.2 59.7 1.6 0.0 
Taenia 1.2 1.9 0.0 2.0 0.8 0.0 
Anoplocephalis 88.4 0.0 0.0 4.4 0.0 0.0 
Monezia 0.0 0.0 9.1 0.0 0.0 0.0 
Hymenolepsis 0.0 1.1 0.0 0.8 0.8 0.0 
Enterobius 0.0 1.1 0.0 0.0 2.5 3.2 
Eimeria Leukarti 0.0 0.0 2.7 0.0 0.0 0.0 
Cryptosporidium 9.1 29.5 12.8 7.3 1.6 3.2 
Echinostoma 0.0 0.2 0.0 0.0 0.0 0.0 
Giardia 9.1 30.6 16.1 15.7 6.6 6.3 
Microsporidia 0.0 0.8 0.0 0.0 1.6 0.0 
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Table 5.3. Measure of aggregation (corrected moment of k) of pathogens found 
within fecal samples collected within and around the Virunga Massif and Bwindi 
Impenetrable Forest National Park in Rwanda and Uganda. 
 
Pathogen Gorilla Human Cattle Baboon Chimpanzee Rodent 
Ascaris -- 0.07 <0.01 0.19 0.11 -- 
Trichostrongyloides 0.16 0.05 0.28 -- -- -- 
Nematodirus 0.05 0.01 0.10 -- -- -- 
Strongyloides 0.05 0.02 0.33 0.08 0.11 -- 
Strongyloidea 0.16 0.10 <0.01 0.11 0.05 -- 
Trichuris 0.03 0.07 0.19 0.05 0.05 -- 
Eimeria Sp. -- -- 0.08 0.18 0.01 -- 
Tania -- <0.01 -- 0.02 <0.01 -- 
Anoplocephalis 0.22 -- -- 0.01 -- -- 
Monezia -- -- 0.15 -- -- -- 
Hymenolepsis -- <0.01 -- <0.01 <0.01 -- 
Enterobius -- <0.01 -- -- 0.02 0.02 
Eimeria Leukarti -- -- <0.01 -- -- -- 
Cryptosporidium <0.01 0.10 0.03 0.03 0.01 0.03 
Echinostoma -- <0.01 -- -- -- -- 
Giardia <0.01 0.08 0.03 0.09 0.03 0.08 
Microsporidia -- <0.01 -- -- 0.01 -- 
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Table 5.4.  Getis-Ord G measure of spatial clustering of pathogens found within 
human fecal samples collected around the Virunga Massif and Bwindi Impenetrable 
Forest National Park in Rwanda and Uganda. 
 
Species Pathogen Gi z p 
Human Ascaris 0.001 -1.2 0.23 
 Cryptosporidium 0.004 16.7 <0.01 
 Giardia 0.004 16.7 <0.01 
 Trichostongyloides 0.002 0.5 0.62 
 Nematodirus 0.004 1.1 0.27 
 Strongyloides 0.001 1.7 0.09 
 Strongyloidea 0.002 0.2 0.84 
 Trichuris 0.002 2.2 0.03 
 Tania 0.002 0.1 0.92 
 Hymenolepsis 0.002 0.02 0.99 
 Enterobius 0.002 0.02 0.99 
 Echinostoma 0.002 0.03 0.98 
 Microsporidium 0.001 0.02 0.99 
     
Cattle Ascaris 0.002 0.14 0.88 
 Cryptosporidium 0.0002 -0.54 0.58 
 Giardia 0.0003 -0.55 0.58 
 Trichostongyloides 0.001 0.03 0.96 
 Nematodirus 0.0004 -0.10 0.92 
 Strongyloides 0.002 0.44 0.66 
 Trichuris 0.002 0.32 0.75 
 Eimeria sp 0.001 -0.42 0.68 
 Monezia 0.001 -0.24 0.81 
 
 





Figure 5.1.  Distribution of samples from the IMPACT system around the Virunga Massif regions of Rwanda, 
Uganda, and Democratic Republic of Congo. 
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Figure 5.3. Pathogen distribution in mountain gorillas (Gorilla beringei) in Rwanda 
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Figure 5.4. Pathogen distribution in humans around the protected area in Rwanda that 








































































































































Figure 5.5. Pathogen distribution in cattle around the protected areas in Rwanda and 




































Figure 5.6. Categorical pathogen distribution in mountain gorillas (Gorilla beringei) in 













































































Figure 5.7. Categorical pathogen distribution in humans around the protected areas in 




































Figure 5.8. Categorical pathogen distribution in cattle around the protected areas in 

















































































Figure 5.9. Categorical pathogen distribution in baboon (Papio hamadryas) around the 































































































































Figure 5.10. Categorical pathogen distribution in rodents around the protected areas in 







































































































Figure 5.11. Categorical pathogen distribution in chimpanzees (Pan troglodytes) 























































Figure 5.11 (cont.). 
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Figure 5.12. Highly clustered spatial distribution of Cryptosporidium within human fecal samples collected around the 
Virunga Massif (Volcanoes National Park) in Rwanda. 





Figure 5.13. Highly clustered spatial distribution of Giardia within human fecal samples collected around the Virunga 
Massif (Volcanoes National Park) in Rwanda.





Figure 5.14.  Clustered spatial distribution of Trichuris within human fecal samples collected around the Virunga Massif 
(Volcanoes National Park) in Rwanda.





Figure 5.15.  Nonclustered spatial distribution of Ascaris within human fecal samples collected around the Virunga Massif 
(Volcanoes National Park) in Rwanda.





Figure 5.16.  Nonclustered spatial distribution of Trichostrongyloides within cattle fecal samples collected around the 












Wildlife health is rapidly becoming an issue of greater global public concern.  
Free-ranging wildlife are vectors of important human diseases.  Issues such as West 
Nile virus in the U.S. and high pathogenic avian influenza virus throughout Europe 
and Asia have brought wildlife health to the main stream.  Although the relevance of 
disease for wildlife populations has been recognized for many years (Leopold 1933, 
Carson 1962, Morner 2002), there is increasing understanding within wildlife and 
veterinary communities of the role of disease management in conservation and human 
health (Meffe 1999).  Typically, in popular media coverage of wildlife disease issues, 
wildlife are identified as a source of a pathogen that affects either livestock or humans 
(Kruse et. al. 2004).  Only recently has there been a broader recognition that wildlife 
populations may be negatively affected by transmission of diseases from domestic 
animals and interactions with humans (Daszak et. al. 2000).  
The highly endangered mountain gorilla (Gorilla beringei) is one such species 
that has the potential to be impacted by domestic animals and humans.  Ironically, the 
eco-tourism industry established in the 1970’s to promote awareness and generate 
financial support for gorilla conservation also may be one of the greatest threats to 
their survival.  Hastings et. al. (2000) estimated a near complete devastation of the 
gorilla population if the introduction of measles from humans ever occurred.  Because 
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ecotourism associated with the gorillas has become such a large source of income for 
host countries, concern over the health of the animals is high.  Disease surveillance is 
essential for timely response to outbreaks and delivery of individual-based medical 
care.  However, in the past, health monitoring and intervention has been haphazard 
and arbitrary.  A systematic approach has been needed to aid in the monitoring and 
surveillance of gorilla health. 
The research presented herein laid the foundation for the development and 
testing of a health information monitoring system for the mountain gorillas.  This 
modular, internet-based system is called the Internet-supported Management Program 
to Assist Conservation Technologies or IMPACT.  The system was designed as a 
multi-component, data collection, entry, and management system, built around a 
relational database.  At the heart of the system is a species database that can 
accommodate repeated observations of individual known or unknown animals.  This 
allows for analysis of health history of individuals, which is important for highly 
endangered species such as the mountain gorilla, or population level analysis for 
epidemiological monitoring.  The system also incorporates spatial locations of 
observations to facilitate spatio-temporal analyses within or among species.  
Therefore, the system is not limited to epidemiological analysis of individual species, 
but is ecosystem oriented.  
The component development approach also makes the system expandable.  
Under this research, the syndromic surveillance system and sample collection and test 
result components were developed and tested.  Other modules, including post mortem 
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examinations, chemical immobilizations, and behavioral information can and should 
be developed in the future.  
Development of the initial components of the system was limited by end-user 
skill levels and hardware infrastructure.  Because the system is used on an 
international basis, development must be based around the least common 
denominator.  In this case, the literacy level of individuals collecting data in the field 
may not be that of a professionally trained veterinarian or veterinary technologist.  
Those individuals collecting data on the syndromic surveillance system usually have 
a very limited education level and often only speak a native language (i.e., Swahili).  
Similarly, connection to the internet for an internationally accessible program is 
required.  Internet connections in the rural portions of Africa are poor at best and non-
existent in many areas.  Therefore, the program size, in terms of internet page size, 
must be very small to be effective in the field.  The IMPACT program has been 
designed to operate under these constraints 
One objective of program development was to produce a means by which 
veterinarians can more objectively provide evidence to the host governments for the 
treatment or care for the gorillas.  Under the current situation, gorilla researchers and 
veterinarians could only provide medical intervention if an individual was in a life 
threatening situation.  This often could be interpreted as, a) if it is immediately life 
threatening or b) some situation that the non-medically oriented governmental 
officials have had past experience in understanding the potential threat (i.e., snares 
causing gangrenous infection).  However, “simple” disease situations such as 
respiratory diseases are generally not seen as life threatening, even though the largest 
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degree of mortality in infants can be attributed to this class of illness (Nutter et. al. 
2005).  
Thus, the IMPACT system was designed as a quantitative means of assessing 
outbreak situations in the gorillas.  With this quantitative assessment, a decision tree 
was developed to determine how data should be collected and analyzed to determine 
situations where intervention would be required.  Development of the decision tree 
forced researchers to determine the manner in which data should and could be 
collected on the animals. The syndromic system developed uses 7 parameters of the 
animal and specific signs within the parameters as indicators of health.  Within each 
sign, a level of severity also was developed.  Although the observation system was 
initially designed to be used by trained health personnel; it was decided that the 
system had to be simplified for the lay trackers and guides to collect data.  This was 
required because the veterinarians are not available to conduct daily observations. 
Thus, the system was developed as a multi-tiered observation system with the 
trackers and guides providing daily observations and veterinarians following up with 
more detailed observations when problems were noted. 
The system also is designed to help distinguish between outbreak and non-
outbreak conditions.  By definition, an outbreak is a disease occurrence in which the 
number of cases exceeds that which would normally be expected.  The problem with 
this definition is there that it requires estimates of normal background levels of 
abnormalities in mountain gorillas and this information is limited.  Rwego (2004) 
conducted 86 observations on mountain gorillas of a single group and provided some 
baseline information.  His sample size, however, was inadequate to provide seasonal 
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and gender/age class specific information.  Similarly, the data collected during this 
research was too limited to provide annual baseline values.  Thus, it is recommended 
that a complete year of data be collected for each gorilla group to develop these 
baseline rates.  Until then, the estimates developed by experienced field veterinarians, 
augmented by ongoing monitoring should be used. 
With the implementation of any program, training of the users is required.  A 
detailed training program on the use of the IMPACT was developed.  The regional 
field veterinarians were trained on the definition of the parameters and signs.  
Standardized photos were used to pictorially demonstrate each sign.  The regional 
veterinarians were then used as the trainers for the trackers and guides within their 
region.  This was done to ensure each observer or potential observer was trained 
using the same material and would be able to identify and classify the parameters and 
signs in a consistent manner. 
Results from this study indicate that, despite training, the veterinarians and 
tracker/guide groups do not observe the gorillas in the same manner.  During a typical 
observation, the trackers and guides showed a tendency to observe more animals and 
more parameters than the veterinarians.  The exceptions were the parameters of 
respiration and discharge from parts of the body other than the head.  Additionally, 
the trackers and guides observed the gender/age classes differently than the 
veterinarians.  Trackers and guides tended to observe gender/age classes in a manner 
that coincides with the social structure of the gorillas (Watts 1996).   
This research also brought together many years of fecal data collection on the 
mountain gorilla, domestic livestock and humans that had occurred in the Virunga 
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Massif and Bwindi Impenetrable National Forest areas.  The system now includes 
fecal sample information from 149 cattle, 248 baboons, 114 gorillas, 122 
chimpanzees, 63 rodents, and >1500 humans samples and 146 health observations for 
gorilla groups.  
Even with all these samples, spatial analysis of differing species within the 
same geographic region was not possible.  Historically, the data collection for each 
species was localized to a very small portion or portions of the region.  This very 
clearly shows how studies to examine spatial aggregation of parasite or disease across 
species and landscapes needs to be conducted within the sampling framework of a 
well-designed study.  Convenience sampling is not likely to provide the data required 
to examine complex spatio-temporal interactions among species.  That is not to say 
that this combining of data was not a worth while venture.  Combing the data 
provided evidence that, either Cryptosporidium or Giardia are highly aggregated in 
the exact same fashion, or some of the test results from projects are suspect.  
Combined results indicated that humans carry the highest pathogen loads of any 
species compared in the area.  Many of these pathogens are zoonotic with the gorillas.  
This points to a need to improve human health care in the vicinity of the gorilla parks 
or institute prevention strategies to protect the gorillas.  Positive results from the 
study indicated that most pathogens are distributed in a negative binomial distribution 
within hosts.  A negative binomial distribution is a general indication of a healthy 
parasite-host relationship (Wilson et. al. 2004).   
 The combination of these data from disparate research projects does provide 
the ability to conduct preliminary analyses and create working hypotheses with which 
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to develop future research.  Analyses from these types of data are only preliminary 
and do not have strong statistical rigor, and should always be expressed as such.  This 
system does illustrate how combining multiple data sets of different type can provide 
insights into the risk of pathogen flow between species.  In the future, the locational 
information of the gorilla observations can be combined with the fecal sample results 
from individuals within that group to provide additional information regarding 
movements of pathogen laden or pathogen free gorillas across the landscape.   
 Ultimately, the ideal sampling and analysis system would have daily input on 
observations of individual gorillas within groups and consistent collection of samples 
from each group (with consistent individuals sampled) over time.  Coupled with that 
would be collection of livestock, wildlife and human samples using a spatial sampling 
scheme that is representative of the region within and around the gorilla parks.  Such 
a sampling design would allow examination of transmission of common pathogens 
between species.  
 It is recommended that the development of IMPACT be continued to include 
more comprehensive test results from multiple sample types such as blood, urine, and 
tissue.  Additionally, modules to incorporate behavioral data, interventions, and post-
mortem examinations need to be developed.  The capabilities to conduct individual 
and/or group level analyses needs to be enhanced.  Individual assessment of gorillas 
and pathogens could be enhanced with the use of polymerase chain reaction (PCR) 
technology to ensure differentiation of species/individuals. The ability to incorporate 
digital media (i.e., pictures, or video) from observations, samples, and post-mortem 
examinations would greatly enhance the ability of researchers in the future to identify 
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and detect disease and abnormalities.  Additional information that might also 
influence animal health would be changes in the vegetation patterns that might impact 
carrying capacity of the parks or climate patterns that might influence outbreaks.  
Finally, as the amount and quality of data increases within the system, an assessment 
of the association of clinical signs to disease diagnosis needs to occur.  Development 
of predictive models that can rapidly determine disease outbreaks would allow 
veterinarians to intervene at earlier stages and possibly prevent an epidemic and loss 
of life.  The goal of this system is the long-term persistence of this valuable wildlife 
species. 
 An overall system needs to address that health of more than the mountain 
gorillas.  Livestock and human health are but 2 other arenas that need to be 
monitored.  Other organizations or Non-governmental Organizations (NGO’s) need to 
brought into the area to collaborate with MGVP.  The assessment of an ecosystem 
and its health is a job far too massive for one organization.  Even if the IMPACT 
system can handle the data and analyses, MGVP cannot handle the requirements of 
all issues beyond those of the gorillas. 
 Funding for this research was provided by the Morris Animal Foundation, the 
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